<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 06 DISEASES | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.06/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.06/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|06|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|06" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.06"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 06 DISEASES | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.06/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.06/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|06" data-search-heading="">
                  <span title="Subtitle 06 DISEASES">Subtitle 06 DISEASES</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|06">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.06">Subtitle 06 DISEASES</h1>
                <h2 id="/us/md/exec/comar/10.06.01" data-order="|10|06|01|" data-ref-path="10|06|01" class="h__chapter">Chapter 01 Communicable Diseases and Related Conditions of Public Health Importance</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 30, 1944</p>
                  <p>Amended April 1, 1966</p>
                  <p>Regulation .55 effective May 15, 1953</p>
                  <p>Regulation .56 effective October 18, 1951</p>
                  <p>Regulation .57 effective April 1, 1966</p>
                  <p>Regulation .58 effective December 20, 1971</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">.01</a>—.54, .56, and .57 repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.22" title=".22 Sale and Distribution of Reptiles.">.22</a> adopted effective December 26, 1980 (7:26 Md. R. 2420)</p>
                  <p>Regulations .02A and .03B amended as an emergency provision effective June 21, 1983 (10:14 Md. R. 1257); emergency status expired October 21, 1983</p>
                  <p>Regulations .02A and .03B amended effective October 24, 1983 (10:21 Md. R. 1901)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.14#D" title="">Regulation .14D</a> amended as an emergency provision effective March 17, 1981 (8:7 Md. R. 639); emergency status expired August 1, 1981; adopted permanently effective August 17, 1981 (8:16 Md. R. 1365)</p>
                  <p>Regulation .31 adopted as an emergency provision effective September 2, 1980 (7:20 Md. R. 1872); adopted permanently effective February 6, 1981 (8:3 Md. R. 227)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.22" title=".22 Sale and Distribution of Reptiles.">.22</a>, .31, .55, and .58 repealed effective August 7, 1989 (16:15 Md. R. 1650)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.17" title=".17 Syphilis and HIV.">.17</a> and .19—.24 adopted effective August 7, 1989 (16:15 Md. R. 1650)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.18" title=".18 Other Sexually Transmitted Infections.">Regulation .18</a> adopted effective February 19, 1990 (17:3 Md. R. 297)</p>
                  <p>——————</p>
                  <p>Chapter revised effective July 5, 1993 (20:13 Md. R. 1049)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.02" title=".02 Definitions.">Regulation .02</a> amended and Regulation .06G adopted as an emergency provision effective December 3, 1996 (23:26 Md. R. 1856); amended permanently effective March 24, 1997 (24:6 Md. R. 484)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.17#D" title="">Regulation .17D</a> amended as an emergency provision effective December 5, 1997 (24:26 Md. R. 1751); amended permanently effective January 26, 1998 (25:2 Md. R. 76)</p>
                  <p>——————</p>
                  <p>Chapter revised effective January 20, 2003 (30:1 Md. R. 24)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01#B" title="">Regulation .01B</a> amended as an emergency provision effective October 1, 2003 (30:22 Md. R. 1574); amended permanently effective March 1, 2004 (31:4 Md. R. 315)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.02#B" title="">Regulation .02B</a> amended as an emergency provision effective October 1, 2003 (30:22 Md. R. 1574); amended permanently effective March 1, 2004 (31:4 Md. R. 315)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.02#B" title="">Regulation .02B</a> amended as an emergency provision effective July 12, 2007 (34:17 Md. R. 1505); emergency status extended at 35:3 Md. R. 285; amended permanently effective January 14, 2008 (35:1 Md. R. 17)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.02#B" title="">Regulation .02B</a> amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective March 24, 2008 (35:6 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.03#B" title="">Regulation .03B</a> amended as an emergency provision effective October 1, 2003 (30:22 Md. R. 1574); amended permanently effective March 1, 2004 (31:4 Md. R. 315)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.03#B" title="">Regulation .03B</a> amended effective March 13, 2006 (33:5 Md. R. 519)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.03#B" title="">Regulation .03B</a> amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective March 24, 2008 (35:6 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.04" title=".04 Reporting Procedures.">Regulation .04</a> amended effective March 13, 2006 (33:5 Md. R. 519)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.07#B" title="">Regulation .07B</a> amended as an emergency provision effective October 1, 2003 (30:22 Md. R. 1574); amended permanently effective March 1, 2004 (31:4 Md. R. 315)</p>
                  <p>Regulation .08-2A, B amended as an emergency provision effective November 5, 2007 (34:24 Md. R. 2154); amended permanently effective March 24, 2008 (35:6 Md. R. 698)</p>
                  <p>Regulation .17-1 adopted as an emergency provision effective July 12, 2007 (34:17 Md. R. 1505); emergency status extended at 35:3 Md. R. 285; adopted permanently effective January 14, 2008 (35:1 Md. R. 17)</p>
                  <p>——————</p>
                  <p>Chapter revised as an emergency provision effective October 1, 2008 (35:22 Md. R. 1946); emergency status extended at 36:10 Md. R. 714; revised permanently effective April 6, 2009 (36:7 Md. R. 522)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">Regulation .01</a> amended effective April 24, 2017 (44:8 Md. R. 403)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01-1" title=".01-1 Incorporation by Reference.">Regulation .01-1</a> amended effective April 6, 2009 (36:7 Md. R. 522)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.02#B" title="">Regulation .02B</a> amended effective March 28, 2016 (43:6 Md. R. 406); April 24, 2017 (44:8 Md. R. 403)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.03#C" title="">Regulation .03C</a> amended effective April 23, 2018 (45:8 Md. R. 420)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.17" title=".17 Syphilis and HIV.">Regulation .17</a> amended effective April 24, 2017 (44:8 Md. R. 403)</p>
                  <p>Regulation .17-1 repealed effective March 28, 2016 (43:6 Md. R. 406)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.18" title=".18 Other Sexually Transmitted Infections.">Regulation .18</a> amended effective April 24, 2017 (44:8 Md. R. 403)</p>
                  <p>——————</p>
                  <p>Chapter revised effective May 18, 2020 (47:10 Md. R. 516)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01#C" title="">Regulation .01C</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01-1" title=".01-1 Incorporation by Reference.">Regulation .01-1</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.13#D" title="">Regulation .13D</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b), 18-102, 18-103, 18-105, 18-201, 18-201.1, 18-202, 18-205,<br/>18-208, 18-214.1, 18-307, 18-337, and 24-101—24-110, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.01.01" data-order="|10|06|01|.01|" data-ref-path="10|06|01|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#A">A.</span> This chapter does not apply to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) surveillance, reporting, record maintenance, or confidentiality, which are covered by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18.02" title="Chapter 02 HIV and CD4+ Investigations and Case Reporting">COMAR 10.18.02</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18.03" title="Chapter 03 AIDS Investigations and Case Reporting">10.18.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#B">B.</span> This chapter applies to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C">C.</span> This chapter provides regulations for coordinated control efforts for communicable diseases and related conditions by the Department, local health officers, medical laboratory directors, physicians, veterinarians, and other Maryland governmental agencies, as guided by policy statements such as:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C(1)">(1)</span> Recommendations of the Centers for Disease Control and Prevention, such as those of the Advisory Committee on Immunization Practices and the Advisory Council for the Elimination of Tuberculosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C(2)">(2)</span> Recommendations of the National Association of State Public Health Veterinarians, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C(2)(a)">(a)</span> The Compendium of Animal Rabies Prevention and Control, 2016;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C(2)(b)">(b)</span> The Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01#C(2)(c)">(c)</span> The Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2017.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.01-1" data-order="|10|06|01|.01-1|" data-ref-path="10|06|01|.01-1" class="h__section">.01-1 Incorporation by Reference.</h3>
                <p>In this chapter, the following documents are incorporated by reference:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01-1#A">A.</span> Control of Communicable Diseases Manual (American Public Health Association, Twentieth Edition, 2015);</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01-1#B">B.</span> Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 (The Association of Avian Veterinarians, 2017);</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01-1#C">C.</span> Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2017 (The National Association of State Public Health Veterinarians, 2017); and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.01-1#D">D.</span> Compendium of Animal Rabies Prevention and Control, 2016 (The National Association of State Public Health Veterinarians, 2016).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.02" data-order="|10|06|01|.02|" data-ref-path="10|06|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#A">A.</span> The definitions of terms used in the Control of Communicable Diseases Manual are accepted as official and applicable to the control of diseases within this State under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)">(1)</span> Body Fluid.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)">(a)</span> “Body fluid” means an excretion or fluid from a human body that contains visible blood and all other tissues, excretions or fluids including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)(i)">(i)</span> Visible blood or any body fluid that is visibly contaminated with blood;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)(ii)">(ii)</span> Semen or vaginal secretions;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)(iii)">(iii)</span> Amniotic, cerebrospinal, pericardial, peritoneal, pleural, or synovial fluids;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)(iv)">(iv)</span> Saliva in dental procedures; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(a)(v)">(v)</span> All body fluids in situations where it is difficult or impossible to differentiate between body fluids.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(1)(b)">(b)</span> “Body fluid” does not include stool, nasal secretions, sputum, tears, urine, or vomitus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(2)">(2)</span> “Case” means an individual who has laboratory or clinical evidence of being infected by an infectious agent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)">(3)</span> “Case of a condition” means an individual who suffers from a condition that is not caused by an infectious agent, including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)(a)">(a)</span> An animal bite;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)(b)">(b)</span> An adverse reaction to pertussis vaccine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)(c)">(c)</span> Harmful algal bloom related illness;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)(d)">(d)</span> Pesticide related illness; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(3)(e)">(e)</span> Ricin toxin poisoning.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)">(4)</span> “Case (or suspected case) of avian psittacosis” means that a bird has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(a)">(a)</span> Laboratory evidence of Chlamydophila psittaci infection consisting of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(a)(i)">(i)</span> Culture isolation of Chlamydophila psittaci from a clinical specimen;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(a)(ii)">(ii)</span> A positive fluorescent antibody test for Chlamydophila psittaci on a clinical specimen;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(a)(iii)">(iii)</span> A fourfold, or greater, increase in Chlamydophila psittaci antibody in a serologic titer, in two serum specimens obtained at least 2 weeks apart and assayed simultaneously at the same laboratory; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(a)(iv)">(iv)</span> Identification of Chlamydophila psittaci within macrophages in smears stained with Gimenez or Macchiavellos stain or sections of the bird's tissues; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(b)">(b)</span> Clinical evidence of Chlamydophila psittaci infection consisting of an epidemiologic link to an avian case that has laboratory evidence of infection, and has:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(b)(i)">(i)</span> Exhibited one or more signs of psittacosis;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(b)(ii)">(ii)</span> Died;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(b)(iii)">(iii)</span> Been clinically diagnosed as having psittacosis by a licensed veterinarian; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(4)(b)(iv)">(iv)</span> Had gross necropsy findings or histopathological evidence consistent with psittacosis as reported by a veterinary pathologist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(5)">(5)</span> Child Care Facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(5)(a)">(a)</span> “Child care facility” means a licensed, registered, or unlicensed facility, institution, establishment, or home where children receive care or supervision for which money is paid when the child's parent has given the child's care over to another on a regular basis for some portion of a 24-hour day as a supplement to the parent's primary care of the child.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(5)(b)">(b)</span> “Child care facility” includes child care center, day care center, nursery, family day care home, and babysitter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)">(6)</span> Clinical Material.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)(a)">(a)</span> “Clinical material” means:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)(a)(i)">(i)</span> An organism isolated from a clinical specimen;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)(a)(ii)">(ii)</span> Material derived or prepared from a clinical specimen in which evidence of a communicable disease has been identified or detected; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)(a)(iii)">(iii)</span> If the organism or material described in §B(6)(a)(i) and (ii) of this regulation is not available, material from an individual that has already been obtained by the medical laboratory, in the following order of preference: a patient specimen, microbial genetic material, or other laboratory material.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(6)(b)">(b)</span> “Clinical material” includes, for Mycobacterium tuberculosis, one culture obtained from the primary isolate on which the diagnosis of tuberculosis was established.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(7)">(7)</span> “Colonization” means the proliferation of microorganisms on or within one or more body sites without detectable host immune response, cellular damage, or clinical expression.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(8)">(8)</span> “Commissioner” means the Commissioner of Health of the Baltimore City Health Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(9)">(9)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(10)">(10)</span> “Foodborne disease outbreak” means two or more epidemiologically related cases of illness following consumption of a common food item or items, or one case of botulism, cholera, mushroom poisoning, trichinosis, or fish poisoning such as ciguatera poisoning, scombroid poisoning, paralytic shellfish poisoning, and other neurotoxic shellfish poisoning.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)">(11)</span> “Health care provider” includes, but is not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(a)">(a)</span> Physicians;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(b)">(b)</span> Physician assistants;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(c)">(c)</span> Dentists;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(d)">(d)</span> Chiropractors;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(e)">(e)</span> Nurse practitioners;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(f)">(f)</span> Nurses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(g)">(g)</span> Podiatrists;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(h)">(h)</span> Medical examiners;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(i)">(i)</span> Hospital administrators;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(j)">(j)</span> Clinic administrators;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(k)">(k)</span> Dispensary administrators;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(l)">(l)</span> Nursing home administrators; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(11)(m)">(m)</span> Any other licensed health care providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)">(12)</span> Health Care Worker.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(a)">(a)</span> “Health care worker” means a paid or unpaid individual working in a health care setting who has the potential for exposure to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(a)(i)">(i)</span> Infectious materials, including body substances;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(a)(ii)">(ii)</span> Contaminated medical supplies and equipment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(a)(iii)">(iii)</span> Contaminated environmental surfaces; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(a)(iv)">(iv)</span> Contaminated air.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)">(b)</span> “Health care worker” includes, but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(i)">(i)</span> Emergency medical service personnel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(ii)">(ii)</span> Dental personnel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(iii)">(iii)</span> Laboratory personnel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(iv)">(iv)</span> Autopsy personnel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(v)">(v)</span> Nurses;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(vi)">(vi)</span> Nursing assistants;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(vii)">(vii)</span> Physicians;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(viii)">(viii)</span> Physician assistants;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(ix)">(ix)</span> Technicians;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(x)">(x)</span> Therapists;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(xi)">(xi)</span> Pharmacists;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(xii)">(xii)</span> Students and trainees;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(xiii)">(xiii)</span> Contractual staff not employed by the health care facility; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(12)(b)(xiv)">(xiv)</span> Individuals not directly involved in patient care but potentially exposed to infectious agents, for example, clerical, dietary, housekeeping, maintenance, and volunteer personnel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(13)">(13)</span> “Health officer” means the health officer in each of the 23 counties and the Commissioner of Health in Baltimore City, or the duly designated representative of the health officer, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(14)">(14)</span> “Infectious” means capable of being transmitted in a manner that can cause a disease or abnormal condition in an individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(15)">(15)</span> “Invasive disease” means a disease in which an organism is detected in a specimen taken from a normally sterile body site.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(16)">(16)</span> “Normally sterile body site” means a body site except for skin, external ear, oronasopharynx, gastrointestinal tract, urethral meatus, and vagina.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(17)">(17)</span> “Novel influenza A virus infection” means a human case of infection with an influenza A virus subtype that is suspected to be markedly different from currently circulating human influenza A viruses, including, but not limited to, H2, H5, H7, or H9 subtypes.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)">(18)</span> “Outbreak” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(a)">(a)</span> A foodborne disease outbreak;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(b)">(b)</span> Three or more cases of a disease or illness that is not a foodborne outbreak and that occurs in individuals who are not living in the same household, but who are epidemiologically linked;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(c)">(c)</span> An increase in the number of infections in a facility, such as a hospital, long-term care facility, assisted living facility, school, or child care center, over the baseline rate usually found in that facility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(d)">(d)</span> A situation designated by the Secretary as an outbreak; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)">(e)</span> One case of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(i)">(i)</span> Anthrax;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(ii)">(ii)</span> Botulism;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(iii)">(iii)</span> Cholera (imported or seafood related);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(iv)">(iv)</span> Ciguatera poisoning;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(v)">(v)</span> Mushroom poisoning;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(vi)">(vi)</span> Paralytic shellfish poisoning and other neurotoxic shellfish poisoning;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(vii)">(vii)</span> Plague;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(viii)">(viii)</span> Rabies (human);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(ix)">(ix)</span> Smallpox;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(x)">(x)</span> Scombroid poisoning; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(18)(e)(xi)">(xi)</span> Trichinosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)">(19)</span> Pet Animal.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(a)">(a)</span> “Pet animal” means a live animal sold or distributed to the public with or without charge for pleasure or companionship and not for utility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)">(b)</span> “Pet animal” does not include domestic farm animals including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)(i)">(i)</span> Equids;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)(ii)">(ii)</span> Cattle;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)(iii)">(iii)</span> Goats;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)(iv)">(iv)</span> Sheep; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(19)(b)(v)">(v)</span> Swine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)">(20)</span> Pet Store.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)(a)">(a)</span> “Pet store” means a facility that keeps, cares for, and houses animals classified as pet animals for the purpose of sale or distribution to the public.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)(b)">(b)</span> “Pet store” includes but is not limited to a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)(b)(i)">(i)</span> Commercial facility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)(b)(ii)">(ii)</span> Feed store; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(20)(b)(iii)">(iii)</span> Department store.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(21)">(21)</span> “Physician” means an individual licensed to practice osteopathy or medicine by the State, or the physician's designee working under the supervision of the physician.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(22)">(22)</span> “Reptile” means a cold blooded, air breathing vertebrate of the class Reptilia.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(23)">(23)</span> “Secretary” means the Secretary of Health or the Secretary's designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(24)">(24)</span> “Sell” means to sell, hold for sale, or offer for commercial or public distribution, a pet animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(25)">(25)</span> “Seller” means a person who sells, holds for sale, or offers for commercial or public distribution, a pet animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(26)">(26)</span> “Sexually transmitted infection” means an infection which may be spread by sexual intercourse, including oral, anal, or vaginal sexual contact with an infected individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(27)">(27)</span> Skin-Penetrating Body Adornment Procedure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(27)(a)">(a)</span> “Skin-penetrating body adornment procedure” means a process that involves piercing or entering the skin or the mucous membrane of an individual for the purpose of inserting pigmented patterns, jewelry, or other forms of body decoration.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(27)(b)">(b)</span> “Skin-penetrating body adornment procedure” includes body-piercing and tattooing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(27)(c)">(c)</span> “Skin-penetrating body adornment procedure” does not include piercing of an earlobe using a properly disinfected ear-piercing gun and single-use sterile studs and clutches.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(28)">(28)</span> Standard Precautions.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(28)(a)">(a)</span> “Standard precautions” means a group of infection prevention practices that apply to all patients, regardless of suspected or confirmed diagnosis or presumed infection status, given that all blood, body fluids, secretions, excretions except sweat, nonintact skin, and mucous membranes may contain transmissible infectious agents.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(28)(b)">(b)</span> “Standard precautions” includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(28)(b)(i)">(i)</span> Hand hygiene and use of gloves, gown, mask, eye protection, or face shield depending on anticipated exposure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(28)(b)(ii)">(ii)</span> Handling equipment or items in the patient environment likely to have been contaminated with infectious fluids in a manner to prevent transmission of infectious agents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.02#B(29)">(29)</span> “Turtle” means an animal commonly known as a turtle, tortoise, or terrapin.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.03" data-order="|10|06|01|.03|" data-ref-path="10|06|01|.03" class="h__section">.03 Reportable Diseases, Conditions, Outbreaks, and Unusual Manifestations; Submitting Clinical Materials.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#A">A.</span> A person, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.01.04" title=".04 Reporting Procedures.">Regulation .04 of this chapter</a>, shall report the diseases or conditions listed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">§C of this regulation</a>, or any other condition as requested by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#B">B.</span> Upon a positive laboratory finding for a disease or condition listed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">§C of this regulation</a>, or upon request of the Secretary, the director of a medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#B(1)">(1)</span> Submit clinical material to the Department's public health laboratory; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#B(2)">(2)</span> Include information about the clinical material on a form provided by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C">C.</span> List of Reportable Diseases and Conditions.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>HEALTH CARE PROVIDERS,<br/>INSTITUTIONS, AND OTHERS<sup>1</sup></th>
                        <th colspan="2">LABORATORIES</th>
                        <th colspan="2">TIME FRAME FOR REPORTING<sup>2</sup></th>
                      </tr>
                      <tr>
                        <th>Diseases and Conditions</th>
                        <th>Laboratory Evidence of</th>
                        <th>Submit Clinical<br/>Materials to the<br/>Department<sup>3</sup></th>
                        <th>Immediate</th>
                        <th>Within 1 Working Day</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1) An outbreak of a disease of known or unknown etiology that may be a danger to the public health<sup>4</sup></td>
                        <td data-vertical-align="middle">Similar etiological agents from a grouping or clustering of patients</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2) A single case of a disease or condition not otherwise included in this table of known or unknown etiology, that may be a danger to the public health</td>
                        <td data-vertical-align="middle">An etiologic agent suspected to cause that disease or condition</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3) An unusual manifestation of a communicable disease in an individual</td>
                        <td data-vertical-align="middle">An etiologic agent suspected to cause that disease</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3-1) An exposure or potential exposure of a person to a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a></td>
                        <td data-vertical-align="middle">An exposure or potential exposure of a person to a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a></td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4) Acquired immunodeficiency syndrome (AIDS)<sup>6</sup></td>
                        <td data-vertical-align="middle">Refer to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18" title="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">COMAR 10.18</a></td>
                        <td/>
                        <td colspan="2" data-text-align="center" data-vertical-align="middle">Refer to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18" title="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">COMAR 10.18</a></td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5) Amebiasis</td>
                        <td data-vertical-align="middle">Entamoeba histolytica</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6) Anaplasmosis</td>
                        <td data-vertical-align="middle">Anaplasma phagocytophilum</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7) Animal bites</td>
                        <td data-vertical-align="middle">Not Applicable</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8) Anthrax</td>
                        <td data-vertical-align="middle">Bacillus anthracis</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td>(9) Arboviral infections including, but not limited to:<br/>     (a) Dengue fever;<br/>     (b) Eastern equine encephalitis;<br/>     (c) LaCrosse virus infection;<br/>     (d) St. Louis encephalitis;<br/>     (e) Western equine encephalitis;<br/>     (f) West Nile virus infection; <br/>     (g) Yellow fever</td>
                        <td data-vertical-align="middle">Any associated arbovirus including, but not limited to:<br/>     (a) Dengue virus;<br/>     (b) Eastern equine encephalitis virus;<br/>     (c) LaCrosse virus;<br/>     (d) St. Louis encephalitis virus;<br/>     (e) Western equine encephalitis virus;<br/>     (f) West Nile virus;<br/>     (g) Yellow fever virus</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10) Babesiosis</td>
                        <td data-vertical-align="middle">Babesia species</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11) Botulism</td>
                        <td data-vertical-align="middle">Clostridium botulinum, botulinum toxin, or other botulism producing Clostridia</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12) Brucellosis</td>
                        <td data-vertical-align="middle">Brucella species</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(13) Campylobacteriosis</td>
                        <td data-vertical-align="middle">Campylobacter species</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(14) Chancroid</td>
                        <td data-vertical-align="middle">Haemophilus ducreyi</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(15) Chlamydia trachomatis infection, including lymphogranuloma venereum (LGV)</td>
                        <td data-vertical-align="middle">Chlamydia trachomatis</td>
                        <td data-text-align="center" data-vertical-align="middle">X (if LGV strain)</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(16) Cholera</td>
                        <td data-vertical-align="middle">Vibrio cholerae</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(17) Coccidioidomycosis</td>
                        <td data-vertical-align="middle">Coccidioides immitis</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(18) Creutzfeldt-Jakob disease</td>
                        <td data-vertical-align="middle">14-3-3 protein from CSF or any brain pathology suggestive of CJD</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(19) Cryptosporidiosis</td>
                        <td data-vertical-align="middle">Cryptosporidium species</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(20) Cyclosporiasis</td>
                        <td data-vertical-align="middle">Cyclospora cayatensis</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(21) Diphtheria</td>
                        <td data-vertical-align="middle">Corynebacterium diphtheriae</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(22) Ehrlichiosis</td>
                        <td data-vertical-align="middle">Ehrlichia species</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(23) Encephalitis, infectious</td>
                        <td data-vertical-align="middle">Isolation from or demonstration in brain tissue, central nervous system tissue, or cerebrospinal fluid, of any pathogenic organism</td>
                        <td data-text-align="center" data-vertical-align="middle">X (Infectious agents as indicated elsewhere in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">§C of this regulation</a> and viral agents except for HSV)</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(24) Epsilon toxin of Clostridium perfringens</td>
                        <td data-vertical-align="middle">Clostridium perfringens, epsilon toxin</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td>(25) Escherichia coli O157:H7 infection</td>
                        <td data-vertical-align="middle">Escherichia coli O157:H7</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(26) Giardiasis</td>
                        <td data-vertical-align="middle">Giardia species</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(27) Glanders</td>
                        <td data-vertical-align="middle">Burkholderia mallei</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(28) Gonococcal infection</td>
                        <td data-vertical-align="middle">Neisseria gonorrhoeae</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td>(29) Haemophilus influenzae invasive disease</td>
                        <td>Haemophilus influenzae, isolated from a normally sterile site</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(30) Hantavirus infection</td>
                        <td data-vertical-align="middle">Hantavirus</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td>(31) Harmful algal bloom related illness</td>
                        <td data-vertical-align="middle">Not Applicable</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(32) Hemolytic uremic syndrome, post-diarrheal</td>
                        <td data-vertical-align="middle">Not Applicable</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(33) Hepatitis A acute infection</td>
                        <td data-vertical-align="middle">Hepatitis A virus IgM</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(34) Hepatitis, viral (B, C<sup>5</sup>, D, E, G, all other types, and undetermined)</td>
                        <td data-vertical-align="middle">Hepatitis B, C<sup>5</sup>, D, E, and G virus, other types</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(35) Human immunodeficiency virus (HIV)<sup>6</sup></td>
                        <td data-vertical-align="middle">Refer to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18" title="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">COMAR 10.18</a></td>
                        <td/>
                        <td colspan="2" data-text-align="center" data-vertical-align="middle">Refer to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18" title="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">COMAR 10.18</a></td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(36) Influenza- associated pediatric mortality</td>
                        <td data-vertical-align="middle">Influenza virus-associated pediatric mortality in persons younger than 18 years old (if known)</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td>(37) Influenza: novel influenza A virus infection</td>
                        <td data-vertical-align="middle">Isolation of influenza virus from humans of a novel or pandemic strain</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(38) Isosporiasis</td>
                        <td data-vertical-align="middle">Cystoisospora belli (synonym Isospora belli)</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(39) Kawasaki syndrome</td>
                        <td data-vertical-align="middle">Not Applicable</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(40) Legionellosis</td>
                        <td data-vertical-align="middle">Legionella species</td>
                        <td data-text-align="center" data-vertical-align="middle">X (if isolate from human)</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(41) Leprosy</td>
                        <td data-vertical-align="middle">Mycobacterium leprae</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(42) Leptospirosis</td>
                        <td data-vertical-align="middle">Leptospira interrogans</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(43) Listeriosis</td>
                        <td data-vertical-align="middle">Listeria monocytogenes</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(44) Lyme disease</td>
                        <td data-vertical-align="middle">Borrelia burgdorferi</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(45) Malaria</td>
                        <td data-vertical-align="middle">Plasmodium species</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(46) Measles (rubeola)</td>
                        <td data-vertical-align="middle">Measles virus</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(47) Melioidosis</td>
                        <td data-vertical-align="middle">Burkholderia pseudomallei</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(48) Meningitis, infectious</td>
                        <td data-vertical-align="middle">Isolation or demonstration of any bacterial, fungal, or viral species in cerebrospinal fluid</td>
                        <td data-text-align="center" data-vertical-align="middle">X (Infectious agents as indicated elsewhere in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">§C of this regulation</a> and viral agents except for HSV)</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(49) Meningococcal invasive disease</td>
                        <td>Neisseria meningitidis (including serogroup, if known), isolated from a normally sterile site</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(50) Microsporidiosis</td>
                        <td data-vertical-align="middle">Various microsporidian protozoa, including but not limited to Encephalitozoon species</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(51) Mumps (infectious parotitis)</td>
                        <td data-vertical-align="middle">Mumps virus</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(52) Mycobacteriosis, other than tuberculosis and leprosy</td>
                        <td data-vertical-align="middle">Mycobacterium species, other than Mycobacterium tuberculosis complex or Mycobacterium leprae</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(53) Pertussis</td>
                        <td data-vertical-align="middle">Bordetella pertussis</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(54) Pertussis vaccine adverse reactions</td>
                        <td data-vertical-align="middle">Not Applicable</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(55) Pesticide related illness</td>
                        <td data-vertical-align="middle">Cholinesterase below the normal laboratory range</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(56) Plague</td>
                        <td data-vertical-align="middle">Yersinia pestis</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(57) Pneumonia in a health care worker resulting in hospitalization</td>
                        <td data-vertical-align="middle">Various organisms</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(58) Poliomyelitis</td>
                        <td data-vertical-align="middle">Poliovirus</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(59) Psittacosis</td>
                        <td data-vertical-align="middle">Chlamydophila psittaci (formerly Chlamydia psittaci)</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(60) Q fever</td>
                        <td data-vertical-align="middle">Coxiella burnetii</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(61) Rabies (human)</td>
                        <td data-vertical-align="middle">Rabies virus</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(62) Ricin toxin poisoning</td>
                        <td data-vertical-align="middle">Ricin toxin (from Ricinus communis castor beans)</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(63) Rocky Mountain spotted fever</td>
                        <td data-vertical-align="middle">Rickettsia rickettsii</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(64) Rubella (German measles) and congenital rubella syndrome</td>
                        <td data-vertical-align="middle">Rubella virus</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(65) Salmonellosis (nontyphoidal)</td>
                        <td data-vertical-align="middle">Salmonella species, including serogroup, if known</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(66) Severe acute respiratory syndrome (SARS)</td>
                        <td data-vertical-align="middle">SARS-associated coronavirus (SARS-CoV)</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(67) Shiga-like toxin producing enteric bacterial infections</td>
                        <td data-vertical-align="middle">Shiga toxin, shiga-like toxin, or the toxin-producing bacterium</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(68) Shigellosis</td>
                        <td data-vertical-align="middle">Shigella species, including species or serogroup, if known</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(69) Smallpox and other orthopoxvirus infections</td>
                        <td data-vertical-align="middle">Variola virus, vaccinia virus, and other orthopox viruses</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(70) Staphylococcal enterotoxin B poisoning</td>
                        <td data-vertical-align="middle">Staphylococcus enterotoxin B</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(71) Streptococcal invasive disease, Group A</td>
                        <td data-vertical-align="middle">Streptococcus pyogenes, Group A, isolated from a normally sterile site</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(72) Streptococcal invasive disease, Group B</td>
                        <td data-vertical-align="middle">Streptococcus agalactiae, Group B, isolated from a normally sterile site</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(73) Streptococcus pneumoniae invasive disease</td>
                        <td data-vertical-align="middle">Streptococcus pneumoniae, isolated from a normally sterile site</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(74) Syphilis<sup>7</sup></td>
                        <td data-vertical-align="middle">Treponema pallidum<sup>7</sup></td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(75) Tetanus</td>
                        <td data-vertical-align="middle">Clostridium tetani</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(76) Trichinosis</td>
                        <td data-vertical-align="middle">Trichinella spiralis</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(77) Tuberculosis, active disease and suspected active tuberculosis<sup>8</sup></td>
                        <td data-vertical-align="middle">Mycobacterium tuberculosis complex<sup>8</sup></td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(77-1) Tuberculosis, latent infection (LTBI)<sup>9</sup></td>
                        <td data-vertical-align="middle">Mycobacterium tuberculosis complex, latent infection<sup>9</sup></td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(78) Tularemia</td>
                        <td data-vertical-align="middle">Francisella tularensis</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(79) Typhoid or Paratyphoid fever (case, carrier, or both, of Salmonella Typhi or Paratyphi)</td>
                        <td data-vertical-align="middle">Salmonella Typhi</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(80) Vancomycin-intermediate Staphylococcus aureus (VISA) infection or colonization</td>
                        <td data-vertical-align="middle">Intermediate resistance of the S. aureus isolate to vancomycin</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(81) Vancomycin-resistant Staphylococcus aureus (VRSA) infection or colonization</td>
                        <td data-vertical-align="middle">Resistance of the S. aureus isolate to vancomycin</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(82) Varicella (chicken pox), fatal cases only</td>
                        <td data-vertical-align="middle">Varicella-zoster virus (Human herpesvirus 3)</td>
                        <td/>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(83) Vibriosis, non-cholera<sup>10</sup></td>
                        <td data-vertical-align="middle">All non-cholera Vibrio species<sup>10</sup></td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(84) Viral hemorrhagic fevers (all types)</td>
                        <td data-vertical-align="middle">All hemorrhagic fever viruses, including but not limited to Crimean-Congo, Ebola, Marburg, Lassa, Machupo viruses</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(85) Yersiniosis</td>
                        <td data-vertical-align="middle">Yersinia species</td>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">X</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p>Footnotes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C1">1.</span> As required to report in Regulation .04A(1)—(3), (5), and (6) of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C2">2.</span> The time frame for reporting is specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.04#C" title="">Regulation .04C of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C3">3.</span> Clinical material shall be submitted according to <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C4">4.</span> Any grouping or clustering of patients having similar disease, symptoms, or syndromes that may indicate the presence of a disease outbreak.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5">5.</span> Suspected hepatitis C as indicated by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(a)">(a)</span> Any hepatitis C antibody results that are positive;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(b)">(b)</span> Any hepatitis C virus RNA results associated with the results in(a) of this footnote that are qualitative or quantitative, if the results are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(b)(i)">(i)</span> Positive; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(b)(ii)">(ii)</span> Negative; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(c)">(c)</span> Any hepatitis C virus RNA results associated with the results in(a) of this footnote if the hepatitis C virus is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(c)(i)">(i)</span> Detected; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C5(c)(ii)">(ii)</span> Undetected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C6">6.</span> Acquired immunodeficiency syndrome (AIDS) and human immunodeficiency virus (HIV), including CD4+ lymphocyte count and viral load, are reportable under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.18" title="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">COMAR 10.18</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7">7.</span> Suspected syphilis as indicated by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7(a)">(a)</span> Any treponemal or non-treponemal results that are qualitative or quantitative, if the results are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7(a)(i)">(i)</span> Positive;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7(a)(ii)">(ii)</span> Reactive; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7(a)(iii)">(iii)</span> Inconclusive; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C7(b)">(b)</span> Any negative or non-reactive results associated with the positive, reactive, or inconclusive results in(a) of this footnote.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C8">8.</span> Tuberculosis confirmed by culture and suspected tuberculosis as indicated by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C8(a)">(a)</span> A laboratory confirmed acid-fast bacillus on smear;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C8(b)">(b)</span> An abnormal chest radiograph suggestive of active tuberculosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C8(c)">(c)</span> A laboratory confirmed biopsy report consistent with active tuberculosis; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C8(d)">(d)</span> Initiation of two or more anti-tuberculosis medications.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C9">9.</span> Latent tuberculosis infection as indicated when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C9(a)">(a)</span> There is a positive result on an Interferon Gamma Release Assay, Tuberculin Skin Test, or any other test indicating tuberculosis infection; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C9(b)">(b)</span> Active or suspected tuberculosis has been ruled out.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.03#C10">10.</span> Vibriosis, non-cholera, identified in any specimen taken from teeth, gingival tissues, or oral mucosa is not reportable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.04" data-order="|10|06|01|.04|" data-ref-path="10|06|01|.04" class="h__section">.04 Reporting Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A">A.</span> Sources of Reports and to Whom to Report.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(1)">(1)</span> An institution, as specified in Health-General Article, §18-202, Annotated Code of Maryland, and a health care provider who knows of a case of a reportable disease, condition, outbreak, or unusual manifestation shall report it to a health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(2)">(2)</span> A teacher at any public, private, or parochial school or a child care provider at any child care facility shall report an occurrence of a reportable disease or condition, an outbreak, or an unusual manifestation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03" title=".03 Reportable Diseases, Conditions, Outbreaks, and Unusual Manifestations; Submitting Clinical Materials.">Regulation .03 of this chapter</a> to the principal, school nurse, or superintendent or assistant superintendent or designee, who shall transmit to a health officer a report of the name and address of a child who appears to have a reportable communicable disease or who has been exposed to a reportable communicable disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(3)">(3)</span> The master or person in charge of a vessel or aircraft within the territory of the State shall report to the Secretary or a health officer at the nearest port of landing or entry, all known facts relating to the illness and physical condition of an individual aboard the vessel or aircraft who may have a reportable disease or condition, an outbreak, or an unusual manifestation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)">(4)</span> Directors of Medical Laboratories or Laboratories that Possess Biological Agents as Defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(a)">(a)</span> The director of a medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> shall report:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(a)(i)">(i)</span> Laboratory evidence of a reportable condition as specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">Regulation .03C of this chapter</a> from examination of a human specimen acquired from an individual in this State; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(a)(ii)">(ii)</span> Evidence of any other condition as requested by the Secretary.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(b)">(b)</span> The director of a medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> located in a Maryland jurisdiction shall report to the health officer of that jurisdiction.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(c)">(c)</span> The director of a medical laboratory located outside of Maryland shall report to the Secretary.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(d)">(d)</span> If a medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> forwards clinical materials out of State for testing, the originating medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> shall comply with this subsection by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(d)(i)">(i)</span> Reporting the results and submitting the clinical materials; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(d)(ii)">(ii)</span> Ensuring that the results are reported and materials submitted.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(e)">(e)</span> When more than one specimen is taken from a patient during one disease episode, the director of a medical laboratory or a laboratory that possesses a biological agent as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.11.03#B(8)" title="">COMAR 10.10.11.03B(8)</a> need not report every test result of a specimen that shows evidence of the same disease in that patient if:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(e)(i)">(i)</span> At least one positive test result is reported; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(4)(e)(ii)">(ii)</span> A health officer has agreed that all test reports do not need to be reported.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(5)">(5)</span> Any individual having knowledge of an animal bite shall report the bite according to the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02" title="Chapter 02 Communicable Diseases — Rabies">COMAR 10.06.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#A(6)">(6)</span> The owner or operator of a food establishment as defined in Health-General Article, §21-301, Annotated Code of Maryland, shall report to a health officer an occurrence of a reportable disease or condition, an outbreak, or an unusual manifestation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B">B.</span> Method and Content of Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(1)">(1)</span> A person, as listed in §A(1)—(4) of this regulation, shall report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(1)(a)">(a)</span> In writing on a form provided by the Secretary; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(1)(b)">(b)</span> In a format approved by the Secretary, when electronic submittal is available.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)">(2)</span> The report shall include at a minimum the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(a)">(a)</span> Date of the report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(b)">(b)</span> Patient's name including first and last names and middle initial;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)">(c)</span> Residence address of the patient including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)(i)">(i)</span> House or apartment number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)(ii)">(ii)</span> Street;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)(iii)">(iii)</span> City or town;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)(iv)">(iv)</span> State; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(c)(v)">(v)</span> Zip code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(d)">(d)</span> Telephone number including area code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(e)">(e)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(f)">(f)</span> Sex;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(g)">(g)</span> Race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(h)">(h)</span> Ethnicity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(i)">(i)</span> Pregnancy status if applicable; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(2)(j)">(j)</span> Other epidemiologic information as specified by the Secretary or the health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(3)">(3)</span> In addition to what is specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.04#B(2)" title="">§B(2) of this regulation</a>, institutions and health care providers, school and child care facility personnel, and masters of vessels or aircraft as listed in §A(1)—(3) of this regulation shall report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(3)(a)">(a)</span> The date of onset of symptoms;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(3)(b)">(b)</span> The diagnosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(3)(c)">(c)</span> For syphilis, gonococcal infection, and Chlamydia trachomatis infection, the treatment given; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(3)(d)">(d)</span> Any laboratory information supporting the diagnosis of the disease or condition, as requested.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)">(4)</span> A director of a medical laboratory, in addition to what is specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.04#B(2)" title="">§B(2) of this regulation</a>, shall report the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(a)">(a)</span> Name, address, telephone number, and federal Clinical Laboratory Improvement Amendments (CLIA) certificate number of the laboratory performing the test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(b)">(b)</span> Date the specimen was received by the laboratory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(c)">(c)</span> Accession number or other unique identifier for the specimen;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(d)">(d)</span> Type of test performed and the results, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(d)(i)">(i)</span> Reference range;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(d)(ii)">(ii)</span> Quantitative results; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(d)(iii)">(iii)</span> Results of speciating, grouping, or typing of organisms;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(e)">(e)</span> Date of specimen collection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(f)">(f)</span> Type of specimen, for example, blood, urine, stool, or mucus, and the site of specimen collection, for example, cervix, eye;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(g)">(g)</span> Date of the laboratory result;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(h)">(h)</span> Name, address including number and street, city, state, and zip code, and phone number including area code of the health care provider who ordered the test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(i)">(i)</span> Name, address including number and street, city, state, and zip code, and phone number including area code of the facility that ordered the test; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(j)">(j)</span> For hepatitis C infection:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(j)(i)">(i)</span> Signal-to-cut-off ratios and critical values;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(j)(ii)">(ii)</span> Hepatitis A IgM results; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#B(4)(j)(iii)">(iii)</span> Hepatitis B IgM test results.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C">C.</span> Timing of Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(1)">(1)</span> If the Secretary requires an immediate report, the person making the report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(1)(a)">(a)</span> Shall communicate directly with an individual in person or by telephone; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(1)(b)">(b)</span> May not leave a message on an answering device.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(2)">(2)</span> A health care provider and a director of a medical laboratory shall report according to the time frame in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">Regulation .03C of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(3)">(3)</span> School and child care facility personnel, a master of a vessel or aircraft, and the owner or operator of a food establishment shall report immediately.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(4)">(4)</span> A health officer shall transmit to the Secretary, by mail or as otherwise specified by the Secretary, all information obtained:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(4)(a)">(a)</span> Within 24 hours after receiving notice of a disease or condition listed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">Regulation .03C of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(4)(b)">(b)</span> Within a shorter amount of time than 24 hours as specified by the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(5)">(5)</span> The Secretary shall transmit to the health officer of the jurisdiction where the patient resides, by mail or as otherwise specified by the Secretary, all information related to the notice of a reportable condition provided by a director of a medical laboratory located outside of Maryland:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(5)(a)">(a)</span> Within 24 hours after receiving notice of a disease or condition listed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.03#C" title="">Regulation .03C of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.04#C(5)(b)">(b)</span> Within a shorter amount of time than 24 hours as specified by the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.05" data-order="|10|06|01|.05|" data-ref-path="10|06|01|.05" class="h__section">.05 Record Maintenance and Confidentiality.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#A">A.</span> The custodian of a report identifying an individual that was filed by a reporting source (Regulation .04A) in compliance with the provisions of Health-General Article, §§18-201, 18-202, and 18-205, Annotated Code of Maryland:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#A(1)">(1)</span> Shall keep the report and record confidential;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#A(2)">(2)</span> May not open a report or record to public inspection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#A(3)">(3)</span> Shall release a report or record or respond to a subpoena for a report or record in criminal or civil proceeding only pursuant to court order sealing the record; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#A(4)">(4)</span> Shall make a record or report available to a governmental agency performing its lawful duties as authorized by an act of the Maryland General Assembly or the United States Congress when the Secretary determines that the release of information is necessary to protect the public health or to prevent the spread of an infectious or contagious disease.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#B">B.</span> A report identifying an individual that was filed by a reporting source, as set forth under <a class="internal-link " href="/us/md/exec/comar/10.06.01.04#A" title="">Regulation .04A of this chapter</a>, in compliance with the provisions of Health-General Article, §§18-201, 18-202, and 18-205, Annotated Code of Maryland, and all information collected in connection with a report, are not medical records under Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C">C.</span> Communication with a Health Care Provider or Patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(1)">(1)</span> The Secretary or a health officer may discuss a laboratory report with the attending physician or other health care provider caring for a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(2)">(2)</span> The Secretary or a health officer may communicate with a patient directly to discuss a laboratory report if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(2)(a)">(a)</span> The physician or other health care provider caring for a patient is not reasonably available; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(2)(b)">(b)</span> The Secretary or health officer records the date and time of the efforts to contact the physician or other health care provider caring for the patient and documents the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(2)(b)(i)">(i)</span> Name of the individual with whom a message was left; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.05#C(2)(b)(ii)">(ii)</span> Identification given by the answering machine, if a message was left on an answering machine.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.06" data-order="|10|06|01|.06|" data-ref-path="10|06|01|.06" class="h__section">.06 General Control Measures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#A">A.</span> Necessary Action. The Secretary or health officer shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#A(1)">(1)</span> Take any action or measure necessary to prevent the spread of communicable disease or to control a reportable disease and condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#A(2)">(2)</span> Issue, when necessary, special instructions for control of a disease or condition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#B">B.</span> Epidemiologic Investigations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#B(1)">(1)</span> A health officer shall respond to each reported outbreak or suspected outbreak of disease within the health officer's jurisdiction in order to collect data to assist in establishing adequate control measures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#B(2)">(2)</span> A health officer shall investigate a reported case or suspect case of a condition as requested by the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#B(3)">(3)</span> The Secretary may, in conjunction with the health officers, conduct the epidemiologic investigation for each reported case or suspected case in an outbreak involving two or more jurisdictions or states.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#B(4)">(4)</span> An individual, a business, a facility, or an agency, including a health care provider, school or child care facility personnel, a master of a vessel or aircraft, or a medical laboratory director, shall make available to the Secretary or a health officer all records and information necessary to the epidemiologic response or investigation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#C">C.</span> A health officer or the Secretary shall order cessation of operation of a business or facility determined or suspected to be a threat to public health until the public health threat is determined by the health officer to have ceased.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D">D.</span> Carrier Approval.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(1)">(1)</span> A health officer shall grant or deny approval to a carrier of an infectious agent to work in any of the following occupations involving:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(1)(a)">(a)</span> Care of young children;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(1)(b)">(b)</span> Care of the elderly;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(1)(c)">(c)</span> Food handling; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(1)(d)">(d)</span> Patient care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(2)">(2)</span> A health officer shall grant or deny approval to a carrier of an infectious agent to attend a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(2)(a)">(a)</span> School; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(2)(b)">(b)</span> Child care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)">(3)</span> A health officer shall consider the following when granting or denying approval to a carrier of an infectious agent to work in occupations or to attend settings listed under §D(1) and (2) of this regulation:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(a)">(a)</span> The seriousness of the disease;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(b)">(b)</span> The route or routes of transmission of the disease;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(c)">(c)</span> The contagiousness of the disease;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(d)">(d)</span> The behavior, neurological development and condition, and physical condition of the carrier;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(e)">(e)</span> The susceptibility to the disease of those likely to be exposed to the carrier in the occupation or setting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(f)">(f)</span> The precautions that may be taken to minimize or eliminate the danger of transmission; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#D(3)(g)">(g)</span> Precedents in the practice of public health.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E">E.</span> Control of Food Handlers. A case with any of the following diseases may not serve or handle, in any manner whatsoever, food intended for public consumption:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(1)">(1)</span> Disease causing diarrhea, unless physician-certified as noninfectious;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(2)">(2)</span> Cholera;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(3)">(3)</span> Escherichia coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC), as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-3" title=".08-3 Escherichia coli O157:H7 and Other Shiga-Like Toxin Producing Escherichia coli (STEC).">Regulation .08-3 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(4)">(4)</span> Hepatitis A, as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.10" title=".10 Hepatitis, Viral Type A.">Regulation .10 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(5)">(5)</span> Salmonellosis, as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.16" title=".16 Salmonellosis.">Regulation .16 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(6)">(6)</span> Shigellosis, as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.19" title=".19 Shigellosis.">Regulation .19 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#E(7)">(7)</span> Typhoid or Paratyphoid fever or carrier of Salmonella Typhi or Paratyphi, as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.21" title=".21 Typhoid Fever (Salmonella Typhi) and Paratyphoid Fever (Salmonella Paratyphi A, Salmonella Paratyphi B tartrate negative, and Salmonella Paratyphi C).">Regulation .21 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#F">F.</span> Control of Communicable Diseases in Schools and Child Care Facilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#F(1)">(1)</span> A health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#F(1)(a)">(a)</span> Maintain the right to make physical inspections of pupils, teachers, or other persons attending, employed, or volunteering in schools or child care facilities whenever, in the judgment of the health officer, the inspections are necessary to investigate a suspected communicable disease; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#F(1)(b)">(b)</span> Determine whether enrollees, pupils, or other individuals attending schools or child care facilities have received the immunizations required under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04" title="Chapter 04 School Health Services and Required Immunizations Before Entry into School">COMAR 10.06.04</a>, 13A.15.03.02, or 13A.16.03.04.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#F(2)">(2)</span> The principal or other person in charge of any school or child care facility shall comply with a measure or special instruction issued by the Secretary or a health officer under <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#A" title="">Regulation .06A of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#G">G.</span> Use of Sterile Instruments or Equipment. An individual who performs a procedure that penetrates the skin or mucous membrane of another individual shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#G(1)">(1)</span> Utilize only sterile instruments or equipment for the procedure;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#G(2)">(2)</span> Discard, after a single use, in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06" title="Chapter 06 Communicable Disease Prevention — Handling, Treatment, and Disposal of Special Medical Waste">COMAR 10.06.06</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.11" title="Chapter 11 Special Medical Wastes">26.13.11</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.12" title="Chapter 12 Standards Applicable to Generators of Special Medical Waste">26.13.12</a>, any instruments or equipment designed for single use; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#G(3)">(3)</span> Clean and sterilize before reuse any instruments or equipment designed for multiple use.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H">H.</span> Skin-Penetrating Body Adornment Procedures — Infection Control.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)">(1)</span> An individual who performs a skin-penetrating body adornment procedure shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(a)">(a)</span> Disclose the risks of the procedure, obtain the client's written consent for the performance of the procedure or, in the case of a minor, the consent of the parent or guardian, and retain the consent on file for a period of 3 years and make it available to the health officer, if requested;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(b)">(b)</span> Maintain records of the name of the customer, the date and type of procedure performed, and the technician performing the procedure for a period of 3 years and make these records available to the health officer, if requested;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(c)">(c)</span> Perform the procedure in a separate, enclosed room that has adequate lighting, and floors, walls, and a ceiling that are constructed to be smooth, impervious, and washable;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(d)">(d)</span> Use only sterile instruments, equipment, and bandages;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(e)">(e)</span> Wash both hands using soap and running water and dry the hands using individual single-use towels before and after each procedure;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(f)">(f)</span> Wear single-use disposable latex or vinyl gloves for each procedure and discard the gloves after the procedure is completed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(g)">(g)</span> Wear a gown and face shield, or goggles and a mask, if spattering of blood is likely to occur during the procedure;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(h)">(h)</span> Cleanse the client's skin before and after the procedure;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(i)">(i)</span> Discard, after a single use, in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06" title="Chapter 06 Communicable Disease Prevention — Handling, Treatment, and Disposal of Special Medical Waste">COMAR 10.06.06</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.11" title="Chapter 11 Special Medical Wastes">26.13.11</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.12" title="Chapter 12 Standards Applicable to Generators of Special Medical Waste">26.13.12</a>, any instruments or equipment designed for single use or any blood-soiled article;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(j)">(j)</span> Clean and sterilize before reuse any instruments or equipment designed for multiple use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(k)">(k)</span> Provide written after-care instructions to the client;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(l)">(l)</span> Use standard precautions in all situations where exposure to blood or body fluids may occur and comply with all applicable State and federal laws and regulations regarding worker protection; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(1)(m)">(m)</span> Post the following notice in a prominent place:</p>
                <p class="quote center ">"NOTICE"</p>
                <p class="quote ">Any procedure that involves penetrating the skin, such as body piercing or tattooing, carries some risks.</p>
                <p class="quote ">The risks from such procedures include: pain, bleeding, swelling, infection at the site of the procedure, transmission of blood-borne infections, scarring, and nerve damage.</p>
                <p class="quote ">The technician performing your procedure should:</p>
                <p class="quote ">* Obtain written consent for the procedure.</p>
                <p class="quote ">* Properly wash his/her hands.</p>
                <p class="quote ">* Cleanse your skin.</p>
                <p class="quote ">* Use sterile instruments, equipment, and bandages.</p>
                <p class="quote ">* Use proper technique to prevent infection at the site of the procedure.</p>
                <p class="quote ">* Provide you with written instructions to tell you what to expect about healing and how you should care for the area after the procedure has been done."</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(2)">(2)</span> An individual who performs a procedure that penetrates the skin or mucous membrane may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(2)(a)">(a)</span> Perform a procedure on skin or mucous membrane that has a rash, infection, or other lesion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(2)(b)">(b)</span> Perform a procedure when the person performing the procedure has an infected or bleeding lesion on the hands;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(2)(c)">(c)</span> Use a styptic pencil or alum block to staunch bleeding; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(2)(d)">(d)</span> Reuse instruments or equipment intended for single use.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.06#H(3)">(3)</span> A health officer may investigate complaints received regarding compliance with this section.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.07" data-order="|10|06|01|.07|" data-ref-path="10|06|01|.07" class="h__section">.07 Minimum Control Measures for Specific Diseases or Conditions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.07#A">A.</span> The definitions of terms used in the text and the recommendations for control included in the Control of Communicable Diseases Manual are accepted as official and applicable to the control of disease within this State under the regulations of the Secretary, except in those instances in which the recommendations may be in conflict with Regulation .06A or Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.08" title=".08 Amebiasis.">.08</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.21" title=".21 Typhoid Fever (Salmonella Typhi) and Paratyphoid Fever (Salmonella Paratyphi A, Salmonella Paratyphi B tartrate negative, and Salmonella Paratyphi C).">.21</a> of this chapter, in which case the regulations of the Secretary or special instructions of the Secretary or a health officer shall take precedence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.07#B">B.</span> The diseases and conditions described in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.08" title=".08 Amebiasis.">.08</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.21" title=".21 Typhoid Fever (Salmonella Typhi) and Paratyphoid Fever (Salmonella Paratyphi A, Salmonella Paratyphi B tartrate negative, and Salmonella Paratyphi C).">.21</a> of this chapter are subject to specific requirements and control procedures as specified.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.08" data-order="|10|06|01|.08|" data-ref-path="10|06|01|.08" class="h__section">.08 Amebiasis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08#A">A.</span> Control of a Case. A case may not participate in an occupation involving patient care, care of young children or the elderly, and food handling until chemotherapy is completed and 24 hours after diarrhea has ceased.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08#B(1)">(1)</span> A health officer shall investigate household and close contacts whose occupations involve food handling, patient care, and care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08#B(2)">(2)</span> A contact who has diarrhea shall submit three fecal specimens for examination. If a specimen is positive for Entamoeba histolytica, the contact becomes a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08#A" title="">§A of this regulation</a> apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08#C">C.</span> Infection Control. Health care providers shall practice standard precautions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.08-1" data-order="|10|06|01|.08-1|" data-ref-path="10|06|01|.08-1" class="h__section">.08-1 Campylobacteriosis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)">(1)</span> For a case with diarrhea due to or presumed due to campylobacteriosis, a health officer shall restrict or exclude a case from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)(a)">(a)</span> Attending a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)(b)">(b)</span> Participating in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)">(2)</span> For a case who has been without diarrhea for at least 24 hours, unless a health officer otherwise restricts or excludes the case based on <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the case may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)(a)">(a)</span> Attend a child care facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)(b)">(b)</span> Participate in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(2)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(3)">(3)</span> If a health officer has restricted or excluded a case under <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-1#A(1)" title="">§A(1) of this regulation</a> or <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the health officer shall approve resumption of child care attendance or occupational duties when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(3)(a)">(a)</span> The case's fecal cultures are Campylobacter-free on two consecutive specimens collected:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(3)(a)(i)">(i)</span> Not less than 24 hours apart; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(3)(a)(ii)">(ii)</span> If antibiotics have been given, not sooner than 48 hours following discontinuation of antibiotics; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#A(3)(b)">(b)</span> The health officer determines that the likelihood of disease transmission is low.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B">B.</span> Control of Contacts at Increased Risk of Transmitting Campylobacteriosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)">(1)</span> A health officer shall restrict or exclude a contact who has diarrhea from child care or an occupational setting until at least 24 hours after diarrhea ceases if the contact is in the household of a case or is a close contact who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)(a)">(a)</span> Attends a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)(b)">(b)</span> Participates in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(2)">(2)</span> If an individual is a contact of a case as specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-1#B(1)" title="">§B(1) of this regulation</a>, and that individual has diarrhea at the time of the health department's investigation of the case, then the contact shall submit for examination two fecal specimens taken:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(2)(a)">(a)</span> Not less than 24 hours apart; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(2)(b)">(b)</span> If antibiotics have been given, not sooner than 48 hours following discontinuation of antibiotics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#B(3)">(3)</span> If either of the specimens referred to in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-1#B(2)" title="">§B(2) of this regulation</a> is positive for Campylobacter, a health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-1#A" title="">§A of this regulation</a> apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-1#D">D.</span> Control of Carriers. A health care provider shall apply the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-1#A" title="">§A of this regulation</a> to carriers in addition to cases.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.08-2" data-order="|10|06|01|.08-2|" data-ref-path="10|06|01|.08-2" class="h__section">.08-2 Cholera (Vibrio cholera O1 or O139).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)">(1)</span> For a case with diarrhea due to or presumed due to cholera, a health officer shall restrict or exclude a case from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)(a)">(a)</span> Attending a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)(b)">(b)</span> Participating in an occupation involving;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)">(2)</span> For a case who has been without diarrhea for at least 48 hours, unless a health officer otherwise restricts or excludes the case based on <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the case may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)(a)">(a)</span> Attend a child care facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)(b)">(b)</span> Participate in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(2)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(3)">(3)</span> If a health officer has restricted or excluded a case under <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-2#A(1)" title="">§A(1) of this regulation</a> or <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the health officer shall approve resumption of child care attendance or occupational duties when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(3)(a)">(a)</span> The case's fecal cultures are Vibrio-free on two consecutive specimens collected:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(3)(a)(i)">(i)</span> Not less than 24 hours apart; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(3)(a)(ii)">(ii)</span> If antibiotics have been given, not sooner than 48 hours following discontinuation of antibiotics; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#A(3)(b)">(b)</span> The health officer determines that the likelihood of disease transmission is low.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B">B.</span> Control of Contacts at Increased Risk of Transmitting Cholera.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)">(1)</span> A health officer shall restrict or exclude from child care or an occupational setting a contact who has diarrhea, until at least 48 hours after diarrhea ceases, if the contact is in the household of a case or is a close contact who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)(a)">(a)</span> Attends a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)(b)">(b)</span> Participates in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(2)">(2)</span> If an individual is a contact of a case as specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-2#B(1)" title="">§B(1) of this regulation</a>, and that individual has diarrhea at the time of the health department's investigation of the case, then the contact shall submit for examination two fecal specimens taken at:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(2)(a)">(a)</span> Not less than 24 hours apart; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(2)(b)">(b)</span> If antibiotics have been given, not sooner than 48 hours following discontinuation of antibiotics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-2#B(3)">(3)</span> If either of the specimens referred to in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-2#B(2)" title="">§B(2) of this regulation</a> is positive for Vibrio cholera, a health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-2#A" title="">§A of this regulation</a> apply.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.08-3" data-order="|10|06|01|.08-3|" data-ref-path="10|06|01|.08-3" class="h__section">.08-3 Escherichia coli O157:H7 and Other Shiga-Like Toxin Producing Escherichia coli (STEC).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(1)">(1)</span> A case may not attend a child care facility until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(1)(a)">(a)</span> The case’s fecal cultures or stool Shiga-like toxin tests are free of E. coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC) on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(1)(b)">(b)</span> A health officer approves readmission based on the low likelihood of disease transmission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(2)">(2)</span> A case, with or without diarrhea, may not participate in occupations involving food handling, patient care, or care of young children or the elderly until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(2)(a)">(a)</span> The case’s fecal cultures or stool Shiga-like toxin tests are free of E. coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC) on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#A(2)(b)">(b)</span> A health officer approves resumption of occupational duties based on the low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(1)">(1)</span> A health officer shall require a culture of feces or stool Shiga-like toxin test only from a household member or other close contact who attends a child care facility or whose occupation involves food handling, patient care, or care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(2)">(2)</span> A household member or other close contact shall submit for examination two fecal specimens taken at an interval of not less than 24 hours apart.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(3)">(3)</span> If either of the specimens submitted pursuant to <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-3#B(2)" title="">§B(2) of this regulation</a> is positive for E. coli O157:H7, other Shiga-Like Toxin Producing Escherichia coli (STEC), or Shiga-like toxin, a health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.08-3#A" title="">§A of this regulation</a> apply.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(4)">(4)</span> A household member or other close contact who currently has diarrhea or who has had an onset of diarrhea in the past 3 weeks may not attend a child care facility until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(4)(a)">(a)</span> The household member or other close contact is without diarrhea for at least 24 hours and fecal cultures or Shiga-like toxin tests are free of E. coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC) on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(4)(b)">(b)</span> A health officer approves readmission based on the low likelihood of disease transmission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(5)">(5)</span> A contact who currently has diarrhea or who has had an onset of diarrhea within the past week may not participate in occupations involving food handling, patient care, or care of young children or the elderly until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(5)(a)">(a)</span> The contact is without diarrhea for at least 24 hours and fecal cultures or Shiga-like toxin tests are free of E. coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC) on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#B(5)(b)">(b)</span> A health officer approves resumption of occupational duties based on the low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.08-3#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.09" data-order="|10|06|01|.09|" data-ref-path="10|06|01|.09" class="h__section">.09 Foodborne and Waterborne Diseases.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A">A.</span> Control of a Case or Contacts. If one of the following diseases is identified, a health officer shall follow the procedures detailed in this chapter for the specific disease:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(1)">(1)</span> Campylobacteriosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(2)">(2)</span> Cholera;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(3)">(3)</span> Escherichia coli O157:H7 and other Shiga-Like Toxin Producing Escherichia coli (STEC);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(4)">(4)</span> Hepatitis, viral type A;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(5)">(5)</span> Salmonellosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(6)">(6)</span> Shigellosis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#A(7)">(7)</span> Typhoid fever (Salmonella Typhi) or paratyphoid fever (Salmonella Paratyphi A, Salmonella Paratyphi B tartrate negative, and Salmonella Paratyphi C).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#B">B.</span> Investigation and Control Measures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#B(1)">(1)</span> A food establishment as defined in Health-General Article, §21-301, Annotated Code of Maryland, shall provide to a health officer the information the health officer or the Secretary determines to be necessary and pertinent to the investigation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#B(2)">(2)</span> A health officer or the Secretary shall investigate the source, inspect food establishments, and collect samples of suspected foods and clinical specimens from food service workers and cases or contacts in an effort to determine the cause of a foodborne illness.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#B(3)">(3)</span> A health officer or the Secretary shall submit all samples for laboratory examination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.09#B(4)">(4)</span> A health officer or the Secretary may detain a food item, issue a public notice requiring the recall or return of a food item, or prohibit the serving of food at a food service facility, until it is determined whether the food item or the facility is implicated as a source of illness.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.10" data-order="|10|06|01|.10|" data-ref-path="10|06|01|.10" class="h__section">.10 Hepatitis, Viral Type A.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#A">A.</span> Control of a Case. A case may not participate in an occupation involving food handling, patient care, or care of young children or the elderly for 1 week after onset of jaundice, or for 2 weeks after the onset of illness, if not jaundiced.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B">B.</span> Control of Contacts. For an individual who previously has not received hepatitis A vaccine, the physician in attendance or a health officer shall offer a single dose of single antigen hepatitis A vaccine or immune globulin to contacts for prophylaxis:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(1)">(1)</span> As soon as possible, but within 2 weeks of exposure to household, sexual, child care, or other contacts as determined by a health officer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)">(2)</span> According to the following recommendations:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)(a)">(a)</span> For a previously unvaccinated healthy individual 12 months old to 40 years old, single antigen hepatitis A vaccine at the age appropriate dose is recommended;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)(b)">(b)</span> For a previously unvaccinated individual older than 40 years old, immune globulin is recommended and single antigen hepatitis A vaccine may be used if:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)(b)(i)">(i)</span> Immune globulin is not available; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)(b)(ii)">(ii)</span> The individual is healthy; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#B(2)(c)">(c)</span> For a previously unvaccinated child younger than 12 months old, an immunocompromised individual, an individual with chronic liver disease, or an individual for whom vaccine is contraindicated, immune globulin is recommended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.10#C">C.</span> Infection Control. Health care providers shall practice standard precautions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.11" data-order="|10|06|01|.11|" data-ref-path="10|06|01|.11" class="h__section">.11 Hepatitis, Viral Type B.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#A">A.</span> Control of a Case. A physician in attendance upon a case having viral hepatitis type B shall educate that case on the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#A(1)">(1)</span> Risks of sexual transmission, household contact transmission, maternal-infant transmission, and transmission by the sharing of hypodermic needles and other drug paraphernalia;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#A(2)">(2)</span> Availability of hepatitis B vaccine and hepatitis B immune globulin for contacts who have had sexual contact with a case of hepatitis B within the preceding 14 days, contacts who have percutaneous exposures to hepatitis B, and infants born to case mothers who carry hepatitis B virus at delivery, and the need for referring those contacts to health care providers for preventive treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#A(3)">(3)</span> Importance of vaccination for viral hepatitis type A if the case is not already immune by reason of prior infection or prior vaccination; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#A(4)">(4)</span> Importance of testing pregnant women for hepatitis B surface antigen at each pregnancy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B">B.</span> Control of Contacts. A physician or health officer in attendance upon a contact of viral hepatitis type B shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(1)">(1)</span> Educate that contact about the availability of vaccine and hepatitis B immune globulin for contacts with exposure to the case’s blood or other infectious body fluids;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(2)">(2)</span> Recommend preventive treatment consistent with current Centers for Disease Control and Prevention guidelines based on type of exposure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(3)">(3)</span> Require that infants born to hepatitis B surface antigen positive mothers:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(3)(a)">(a)</span> Receive hepatitis B immune globulin and the first dose of hepatitis B vaccine within 12 hours of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(3)(b)">(b)</span> Receive the rest of the vaccination series; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#B(3)(c)">(c)</span> Are tested for hepatitis B surface antigen and hepatitis B surface antibody at 9 to 15 months old.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11#C">C.</span> Infection Control. Health care providers shall practice standard precautions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.11-1" data-order="|10|06|01|.11-1|" data-ref-path="10|06|01|.11-1" class="h__section">.11-1 Hepatitis, Viral Type C.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A">A.</span> Control of a Case. A physician in attendance upon a case of viral hepatitis type C shall educate that case on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)">(1)</span> The risks of transmission of viral hepatitis type C by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(a)">(a)</span> Sharing hypodermic needles and other injecting drug paraphernalia;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(b)">(b)</span> Sexual transmission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(c)">(c)</span> Maternal-child transmission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(d)">(d)</span> Parenteral or permucosal exposure to blood or other infectious body fluids;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(e)">(e)</span> Chronic hemodialysis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(f)">(f)</span> Transfusion; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(1)(g)">(g)</span> Transplantation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(2)">(2)</span> How to reduce the risk of transmission of viral hepatitis type C to other individuals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(3)">(3)</span> The importance of an individual health evaluation to determine if treatment should be recommended;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(4)">(4)</span> The importance of vaccination for viral hepatitis types A and B if the case is not already immune by reason of prior infection or prior vaccination; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#A(5)">(5)</span> The prevention of further liver injury or more serious liver disease or liver failure.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#B">B.</span> Control of Contacts. A physician or health officer in attendance upon a contact of viral hepatitis type C shall educate the contact about:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#B(1)">(1)</span> Any risk factors and signs of infection due to viral hepatitis type C;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#B(2)">(2)</span> Testing that is available to determine whether an infection due to viral hepatitis type C is present, and facilitate that testing if medically appropriate or if requested by the contact; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#B(3)">(3)</span> How to reduce the contact's risk of receiving viral hepatitis type C from others.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#C">C.</span> Infection Control. A health care provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#C(1)">(1)</span> Practice standard precautions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#C(2)">(2)</span> Implement and maintain, in hemodialysis centers and other settings where viral hepatitis type C transmission is known to be an increased risk, additional infection control measures based upon the Centers for Disease Control and Prevention recommendations for prevention and control of hepatitis C infection and HCV-related chronic disease, as directed by the Secretary to reduce disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.11-1#D">D.</span> Education. The Secretary, with the assistance of the health officer, shall provide professional and public education and informational materials on viral hepatitis type C, modes of transmission, and prevention of viral hepatitis type C.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.12" data-order="|10|06|01|.12|" data-ref-path="10|06|01|.12" class="h__section">.12 Measles (Rubeola).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#A">A.</span> Control of a Case. A health officer or health care provider shall recommend that a case may not attend a school, workplace, or child care facility from the onset of the illness at least through the 4th day after the rash appears.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)">(1)</span> Nonimmune Contacts.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(a)">(a)</span> Nonimmune individuals for measles, in general, are people who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(a)(i)">(i)</span> Have not received two doses of measles containing vaccine on or after the first birthday;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(a)(ii)">(ii)</span> Have no documentation of immunity or disease; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(a)(iii)">(iii)</span> Were born in or after 1957.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(b)">(b)</span> A health officer or health care provider shall recommend that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(b)(i)">(i)</span> Nonimmune contacts receive measles vaccine within 72 hours of exposure if not medically contraindicated; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(b)(ii)">(ii)</span> Nonimmune household or other close contacts, particularly contacts younger than 1 year old, pregnant women, persons with immunodeficiencies, or those for whom the vaccine is contraindicated, be given immune globulin within 6 days of exposure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(1)(c)">(c)</span> A health officer shall restrict or exclude a nonimmune contact from attending a school, health care facility, child care facility, or workplace until 21 days after the onset of rash in the last case of measles.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(2)">(2)</span> A health officer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(2)(a)">(a)</span> May require all nonimmune individuals to be excluded from a school, workplace, or child care facility when a case of measles is diagnosed or suspected in a student, employee, or volunteer of the school or facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#B(2)(b)">(b)</span> Shall authorize readmission upon documented proof of immunity in the form of immunization record, serologic test, or the low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#C">C.</span> Infection Control. Health care providers shall practice airborne precautions from the onset of illness at least through the 4th day after the rash appears.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#D">D.</span> Proof of Immunity for Health Care Workers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#D(1)">(1)</span> A worker born in or after 1957 working at least 20 hours each week who is newly retained as medical staff, a direct or contractual employee, or a volunteer of a hospital classified as a “general hospital” under Health-General Article, §19-307, Annotated Code of Maryland, shall have documentation of receipt of two doses of live measles virus vaccine after becoming 1 year old or proof of immunity by blood test for antibody to rubeola. The hospital shall keep the measles vaccination or immunity status of each worker on file.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#D(2)">(2)</span> Exemptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#D(2)(a)">(a)</span> A hospital shall grant a medical exemption for any worker who presents a written statement from a licensed physician or a health officer indicating that immunization against measles is medically contraindicated or detrimental to the worker's health. The statement shall indicate whether the exemption should be permanent or temporary. If the exemption is temporary, the statement shall indicate the date on which the worker is to receive the immunization. A hospital shall withdraw a temporary medical exemption on the day following that date. If the exemption is permanent, the hospital shall maintain a record of the worker's measles antibody test results.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12#D(2)(b)">(b)</span> If a worker objects to an immunization upon the grounds that it conflicts with the worker's bona fide religious beliefs and practices, the hospital shall grant a religious exemption to the worker for the immunization. The hospital shall maintain a record of the worker's measles antibody test results.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.12-1" data-order="|10|06|01|.12-1|" data-ref-path="10|06|01|.12-1" class="h__section">.12-1 Mumps.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#A">A.</span> Control of a Case. A health officer or health care provider shall recommend that a case may not attend a school, workplace, or child care facility from the onset of illness through the 5th day after onset of parotitis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)">(1)</span> Nonimmune Individuals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)(a)">(a)</span> Nonimmune individuals for mumps, in general, are people who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)(a)(i)">(i)</span> Have not received two doses of mumps containing vaccine on or after the first birthday;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)(a)(ii)">(ii)</span> Have no documentation of immunity or disease; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)(a)(iii)">(iii)</span> Were born in or after 1957.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(1)(b)">(b)</span> A health officer shall restrict or exclude a nonimmune contact from attending a school, health care facility, child care facility, or workplace until 25 days after the onset of parotitis in the last case of mumps.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)">(2)</span> A health officer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)(a)">(a)</span> May require all nonimmune individuals to be excluded from a school, workplace, or child care facility when a case of mumps is diagnosed or suspected in a student, employee, or volunteer of the school or facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)(b)">(b)</span> Shall authorize readmission upon documented proof of immunity in the form of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)(b)(i)">(i)</span> An immunization record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)(b)(ii)">(ii)</span> A serologic test; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#B(2)(b)(iii)">(iii)</span> The low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-1#C">C.</span> Infection Control. A health care provider shall practice droplet precautions for 5 days after onset of parotitis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.12-2" data-order="|10|06|01|.12-2|" data-ref-path="10|06|01|.12-2" class="h__section">.12-2 Pertussis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#A(1)">(1)</span> A health officer or health care provider shall recommend that a case may not attend school, a workplace, or a child care facility until the patient has received at least 5 days of appropriate antibiotics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#A(2)">(2)</span> If a case does not receive antibiotics, a health officer shall restrict or exclude the case from attending a school, health care facility, child care facility, or workplace for 3 weeks after onset of cough.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B">B.</span> Control of Contacts. A health officer may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B(1)">(1)</span> Require all inadequately immunized household contacts younger than 7 years old to be excluded from schools, child care facilities, and public gatherings:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B(1)(a)">(a)</span> For 21 days after last exposure; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B(1)(b)">(b)</span> Until the case patients and contacts have received 5 days of appropriate antibiotics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B(2)">(2)</span> Require all contacts to verify immunization status and be brought up to date if not adequately immunized to protect against subsequent exposure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#B(3)">(3)</span> Require antibiotic prophylaxis for contacts of cases.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#C">C.</span> Infection Control. A health care provider shall practice droplet precautions for the shorter of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#C(1)">(1)</span> 21 days after onset of cough; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.12-2#C(2)">(2)</span> When a case has been on appropriate antibiotics for 5 days.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.13" data-order="|10|06|01|.13|" data-ref-path="10|06|01|.13" class="h__section">.13 Psittacosis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.13#A">A.</span> There is no control of a human case or contacts.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.13#B">B.</span> Infection Control. A health care provider shall practice appropriate disinfection and disposal of respiratory discharges.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.13#C">C.</span> The sale and distribution of exotic birds and handling of exotic birds which are cases or suspected cases of avian psittacosis are subject to Health-General Article, §§24-101—24-110, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.13#D">D.</span> The Department recommends that the Compendium of Measures To Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017, by the National Association of State Public Health Veterinarians, be followed for ill birds and birds that carry psittacosis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.14" data-order="|10|06|01|.14|" data-ref-path="10|06|01|.14" class="h__section">.14 Rabies.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.14#A">A.</span> Control of a Case (Human). A health care provider shall apply contact isolation to the case for the period of communicability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.14#B">B.</span> Control of Contacts. A health officer or health care provider shall evaluate individually a close contact or hospital contact to determine the need for post-exposure rabies prophylaxis. A health care provider shall warn an immediate attendant of the hazard of infection.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.14#C">C.</span> Infection Control. A health care provider shall practice contact isolation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.14#D">D.</span> Confinement or Examination of Animals. A health officer or the Maryland Public Health Veterinarian shall direct the quarantine, examination, control, and disposition of any animal that bites or otherwise potentially exposes a human to rabies, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02" title="Chapter 02 Communicable Diseases — Rabies">COMAR 10.06.02</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.15" data-order="|10|06|01|.15|" data-ref-path="10|06|01|.15" class="h__section">.15 Rubella (German Measles).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#A">A.</span> Control of a Case. A health officer or health care provider shall recommend that a case:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#A(1)">(1)</span> Be isolated from a woman of childbearing age who is not immune or is of unknown immunity, from the onset of illness through the 7th day after appearance of the rash; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#A(2)">(2)</span> May not attend a school, workplace, or child care facility from the onset of the illness through the 7th day after the appearance of the rash.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)">(1)</span> Nonimmune Contacts.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)(a)">(a)</span> Nonimmune individuals for rubella, in general, are people who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)(a)(i)">(i)</span> Have not received at least one dose of rubella containing vaccine on or after the first birthday;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)(a)(ii)">(ii)</span> Have no documentation of immunity or disease; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)(a)(iii)">(iii)</span> Were born in or after 1957.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(1)(b)">(b)</span> A health officer shall restrict or exclude a nonimmune contact from attending a school, health care facility, child care facility, or workplace until 21 days after the onset of rash in the last case of rubella.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(2)">(2)</span> A health officer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(2)(a)">(a)</span> May require all nonimmune individuals to be excluded from a school, workplace, or child care facility when a case of rubella is diagnosed or suspected in a student, employee, or volunteer of the school or facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#B(2)(b)">(b)</span> Shall authorize readmission by documented proof of immunity in the form of an immunization record, serologic test, or the low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#C">C.</span> Infection Control. A health care provider shall practice droplet precaution for 7 days after onset of the rash.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#D">D.</span> Proof of Immunity for Health Care Workers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#D(1)">(1)</span> A worker born in or after 1957 working at least 20 hours each week who is newly retained as medical staff, a direct or contractual employee, or a volunteer of a hospital classified as a “general hospital” under Health-General Article, §19-307, Annotated Code of Maryland, shall have documentation of receipt of either one dose of live rubella virus vaccination on or after becoming 1 year old or proof of immunity by blood test for antibody to rubella. The hospital shall keep the vaccine or immunity status of each worker on file.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#D(2)">(2)</span> Exemptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#D(2)(a)">(a)</span> A hospital shall grant a medical exemption for any worker who presents a written statement from a licensed physician or a health officer indicating that immunization against rubella is medically contraindicated or detrimental to the worker's health. The statement shall indicate whether the exemption should be permanent or temporary. If the exemption is temporary, the statement shall indicate the date on which the worker is to receive the immunization. A hospital shall withdraw a temporary medical exemption on the day following that date. If the exemption is permanent, the hospital shall maintain a record of the worker's rubella antibody test results.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.15#D(2)(b)">(b)</span> If a worker objects to an immunization upon the grounds that it conflicts with the worker's bona fide religious beliefs and practices, the hospital shall grant a religious exemption to the worker for the immunization. The hospital shall maintain a record of the worker's rubella antibody test results.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.16" data-order="|10|06|01|.16|" data-ref-path="10|06|01|.16" class="h__section">.16 Salmonellosis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)">(1)</span> For a case with diarrhea due to or presumed due to salmonellosis, a health officer shall restrict or exclude a case from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)(a)">(a)</span> Attending a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)(b)">(b)</span> Participating in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)">(2)</span> For a case who has been without diarrhea for at least 24 hours, unless a health officer otherwise restricts or excludes the case based on <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the case may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)(a)">(a)</span> Attend a child care facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)(b)">(b)</span> Participate in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(2)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(3)">(3)</span> If a health officer has restricted or excluded a case under <a class="internal-link " href="/us/md/exec/comar/10.06.01.16#A(1)" title="">§A(1) of this regulation</a> or <a class="internal-link " href="/us/md/exec/comar/10.06.01.06#D" title="">Regulation .06D of this chapter</a>, the health officer shall approve resumption of child care attendance or occupational duties when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(3)(a)">(a)</span> The case’s fecal cultures are Salmonella-free on two consecutive specimens collected:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(3)(a)(i)">(i)</span> Not less than 24 hours apart; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(3)(a)(ii)">(ii)</span> If antibiotics have been given, not sooner than 48 hours following discontinuation of antibiotics; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#A(3)(b)">(b)</span> The health officer determines that the likelihood of disease transmission is low.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B">B.</span> Control of Contacts at Increased Risk of Transmitting Salmonellosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)">(1)</span> A health officer shall restrict or exclude from child care or an occupational setting a contact who has diarrhea, until at least 24 hours after diarrhea ceases, if the contact is in the household of a case or is a close contact who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)(a)">(a)</span> Attends a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)(b)">(b)</span> Participates in an occupation involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(2)">(2)</span> If an individual is a contact of a case as specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.16#B(1)" title="">§B(1) of this regulation</a>, and that individual has diarrhea at the time of the health department's investigation of the case, then the contact shall submit for examination two fecal specimens taken not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(2)(a)">(a)</span> Less than 24 hours apart; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(2)(b)">(b)</span> Sooner than 48 hours following discontinuation of antibiotics if antibiotics have been given.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#B(3)">(3)</span> If either of the specimens referred to in <a class="internal-link " href="/us/md/exec/comar/10.06.01.16#B(2)" title="">§B(2) of this regulation</a> is positive for Salmonella, a health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.16#A" title="">§A of this regulation</a> apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.16#D">D.</span> Control of Carriers. A health care provider shall apply the same control measures to carriers as to cases.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.17" data-order="|10|06|01|.17|" data-ref-path="10|06|01|.17" class="h__section">.17 Syphilis and HIV.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(1)">(1)</span> For an individual who appears to have or who has syphilis in a stage which is or may become communicable, or HIV, a physician shall instruct the individual in the use of any measure and render any treatment which may be necessary to prevent the spread of the disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(2)">(2)</span> An individual under medical observation for diagnosis of syphilis or HIV shall remain under medical supervision until the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(2)(a)">(a)</span> Observation for diagnosis has been completed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(2)(b)">(b)</span> Syphilis or HIV, if present, has been reported to a health officer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(2)(c)">(c)</span> Individual with syphilis has had the treatment that is necessary for the protection of the public health; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(2)(d)">(d)</span> Individual with HIV has entered into HIV medical care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(3)">(3)</span> A physician shall report to a health officer within 1 working day and in writing the name and address of an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(3)(a)">(a)</span> Receiving or has received treatment for syphilis; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(3)(b)">(b)</span> Under medical observation for diagnosis or treatment of syphilis in an infectious or potentially infectious stage, who fails to return for observation or treatment within 1 week of the date of a missed appointment, and is not known to the attending physician to be under medical observation or treatment elsewhere for this infection.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(4)">(4)</span> A health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(4)(a)">(a)</span> Investigate an individual reported to the health officer under the provisions of <a class="internal-link " href="/us/md/exec/comar/10.06.01.17#A(3)" title="">§A(3) of this regulation</a> or Health-General Article, §18-201.1, Annotated Code of Maryland, who is within the health officer’s territorial jurisdiction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(4)(b)">(b)</span> Take such measures as may be deemed necessary for the protection of the public health; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#A(4)(c)">(c)</span> Forward to the Secretary immediately a report of an individual reported under the provisions of <a class="internal-link " href="/us/md/exec/comar/10.06.01.17#A(3)" title="">§A(3) of this regulation</a> or Health-General Article, §18-201.1, Annotated Code of Maryland, who is outside the health officer’s territorial jurisdiction for referral to the health officer of the proper jurisdiction.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)">(1)</span> A physician in attendance upon a patient having syphilis or HIV:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)(a)">(a)</span> Shall endeavor to bring an individual with whom the patient has had potentially infectious contact to examination and, as appropriate, prophylaxis by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)(a)(i)">(i)</span> Requesting a health officer to conduct a contact investigation of any case of syphilis or HIV; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)(a)(ii)">(ii)</span> Interviewing the patient in order to ascertain the names, descriptions, addresses, telephone numbers, and email addresses of those with whom the patient has had potentially infectious contact;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)(b)">(b)</span> Shall report immediately to a health officer an individual identified as having had potentially infectious contact with a patient having syphilis reported under the provisions of <a class="internal-link " href="/us/md/exec/comar/10.06.01.17#A(3)" title="">§A(3) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(1)(c)">(c)</span> May report to a health officer an individual identified as having had potentially infectious contact with a patient having HIV reported under Health-General Article, §18-201.1, Annotated Code of Maryland, if a patient that has been informed of the patient’s HIV positive status refuses to notify the patient’s sexual and needle-sharing partners.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(2)">(2)</span> A health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(2)(a)">(a)</span> Investigate and notify immediately an individual reported under the provisions of <a class="internal-link " href="/us/md/exec/comar/10.06.01.17#B(1)(b)" title="">§B(1)(b) of this regulation</a>, who is within the health officer’s jurisdiction, of the individual’s exposure and advise the individual to undergo a medical examination to ascertain whether the individual is infected with syphilis or HIV; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(2)(b)">(b)</span> Forward immediately to the Secretary all reports of individuals who are outside the health officer’s territorial jurisdiction for referral to the health officer of the proper jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(3)">(3)</span> A reported individual shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(3)(a)">(a)</span> Within 1 week of notification, be examined to ascertain whether the individual has been infected with syphilis or HIV; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#B(3)(b)">(b)</span> Be treated with a regimen appropriate for the stage of syphilis to which the individual has been exposed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D">D.</span> Congenital Syphilis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)">(1)</span> A physician in attendance upon a pregnant woman shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(a)">(a)</span> Serologically test her for syphilis in accordance with Health-General Article, §18-307, Annotated Code of Maryland, by taking a blood sample and assuring the test is completed:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(a)(i)">(i)</span> At the time the physician first examines the woman, either at the first prenatal visit or at the time of delivery if the woman has had no prenatal care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(a)(ii)">(ii)</span> In the third trimester at the prenatal visit at 28 weeks of gestation or the first prenatal visit after 28 weeks of gestation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(a)(iii)">(iii)</span> At delivery, for high prevalence communities or high risk individuals;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(b)">(b)</span> Render appropriate treatment within 1 week whenever syphilis, in any stage, is diagnosed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(1)(c)">(c)</span> Report the case to a health officer immediately.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)">(2)</span> A physician in attendance upon an infant born to an untreated woman who has a positive serological test for syphilis shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)(a)">(a)</span> Evaluate the infant for possible congenital syphilis and render all indicated treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)(b)">(b)</span> Report immediately to a health officer the following information:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)(b)(i)">(i)</span> The name, address, and telephone number of the mother;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)(b)(ii)">(ii)</span> The results of the serological testing, including titers; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(2)(b)(iii)">(iii)</span> The results of the medical evaluation for congenital syphilis for the infant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(3)">(3)</span> A health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(3)(a)">(a)</span> Investigate immediately an individual reported to the health officer under the provisions of §D(1)(c) and (2)(b) of this regulation, who is within the health officer's jurisdiction; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.17#D(3)(b)">(b)</span> Forward immediately to the Secretary a report of an individual reported under the provisions of §D(1)(c) and (2)(b) of this regulation, who is outside the health officer's jurisdiction for referral to a health officer of the proper jurisdiction.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.18" data-order="|10|06|01|.18|" data-ref-path="10|06|01|.18" class="h__section">.18 Other Sexually Transmitted Infections.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A(1)">(1)</span> Hepatitis, viral type B, as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.11" title=".11 Hepatitis, Viral Type B.">Regulation .11 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A(2)">(2)</span> A physician in attendance upon a person who appears to have, or who has a sexually transmissible disease in a stage which is or may become communicable, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A(2)(a)">(a)</span> Instruct the person on the modes of transmission and the prevention of transmission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A(2)(b)">(b)</span> Render any necessary treatment to the case; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#A(2)(c)">(c)</span> Advise the case to inform a sexual partner or partners of exposure and the need for examination and treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#B(1)">(1)</span> Hepatitis, viral type B as discussed in <a class="internal-link " href="/us/md/exec/comar/10.06.01.11" title=".11 Hepatitis, Viral Type B.">Regulation .11 of this chapter</a></p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#B(2)">(2)</span> A physician in attendance upon an individual who is a sexual contact of a case of a sexually transmitted infection shall perform a medical examination and render indicated treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C">C.</span> Prevention of Gonococcal Ophthalmia Neonatorum.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C(1)">(1)</span> A birth-attending physician or certified nurse-midwife shall apply to both eyes of a newborn one of the following prophylactic agents:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C(1)(a)">(a)</span> A 1-percent silver nitrate solution provided in individual wax ampules for the prevention of gonococcal ophthalmia neonatorum;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C(1)(b)">(b)</span> Tetracycline ophthalmic ointment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C(1)(c)">(c)</span> Erythromycin ophthalmic ointment (USP).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.18#C(2)">(2)</span> A birth-attending physician or certified nurse-midwife shall document in a newborn's medical record the application of the prophylactic agent, the name of the agent used, and dose strength.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.19" data-order="|10|06|01|.19|" data-ref-path="10|06|01|.19" class="h__section">.19 Shigellosis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(1)">(1)</span> A case may not attend a child care facility until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(1)(a)">(a)</span> The case's fecal cultures are Shigella-free on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(1)(b)">(b)</span> A health officer approves readmission based on the low likelihood of disease transmission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(2)">(2)</span> A case, with or without diarrhea, may not participate in occupations involving food handling, patient care, or care of young children or the elderly until:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(2)(a)">(a)</span> The case's fecal cultures are Shigella-free on two consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, if antibiotics have been given; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#A(2)(b)">(b)</span> A health officer approves resumption of occupational duties based on the low likelihood of disease transmission.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B">B.</span> Control of Contacts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)">(1)</span> A health officer shall require a culture of feces only from a household member or close contact who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)(a)">(a)</span> Attends a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)(b)">(b)</span> Whose occupation involves:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)(b)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)(b)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(1)(b)(iii)">(iii)</span> Care of young children or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(2)">(2)</span> A contact shall submit for examination two fecal specimens taken at an interval of not less than 24 hours apart.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#B(3)">(3)</span> If either of the specimens collected under <a class="internal-link " href="/us/md/exec/comar/10.06.01.19#B(2)" title="">§B(2) of this regulation</a> is positive for Shigella, the health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.19#A" title="">§A of this regulation</a> shall apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.19#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.20" data-order="|10|06|01|.20|" data-ref-path="10|06|01|.20" class="h__section">.20 Tuberculosis.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A">A.</span> Control of a Case and Suspected Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(1)">(1)</span> A health care provider shall immediately send notification that they have a patient who is suspected of being in a communicable stage to the local health officer of the jurisdiction in which the patient is currently located.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(2)">(2)</span> A health care provider may not discharge a patient who is suspected of being in a communicable stage until the local health department of the jurisdiction in which the patient is located has been informed of and concurs with the planned discharge or release of the individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(3)">(3)</span> A health officer or health care provider shall isolate a patient who is in a communicable stage as long as the specific microorganism:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(3)(a)">(a)</span> Is excreted by the patient; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(3)(b)">(b)</span> Can be isolated by culture in the case of multidrug resistant tuberculosis (MDR-TB) or extremely drug resistant tuberculosis (XDR-TB).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(4)">(4)</span> A patient fulfills the requirements of isolation as long as the patient receives adequate chemotherapy, is under medical supervision, and observes instructions for isolation issued by a health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(5)">(5)</span> A health care provider shall place individuals with tuberculosis and suspected tuberculosis on a tuberculosis treatment regimen that is in accordance with current national and State standards of care, and that provide for direct observation by a trained health care worker of ingestion of each dose of medication.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(6)">(6)</span> A health officer or health care provider treating an individual with tuberculosis or suspected tuberculosis shall provide human immunodeficiency virus testing and counseling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(7)">(7)</span> A health officer shall monitor the treatment of individuals with tuberculosis and suspected tuberculosis to determine if the treatment is appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(8)">(8)</span> A health officer may impose limitations on travel and place restrictions on hospital discharge for an individual with tuberculosis or suspected tuberculosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(9)">(9)</span> A health officer may remove the limitations and restrictions set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.01.20#A(8)" title="">§A(8) of this regulation</a> when appropriate and consistent with the individual's tuberculosis treatment plan.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(10)">(10)</span> A health officer or the Secretary shall manage tuberculosis patients who are noncompliant with tuberculosis treatment in accordance with Health-General Article, §§18-324 and 18-325, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#A(11)">(11)</span> A health officer may require an individual having tuberculosis in a noncommunicable stage to be under medical supervision, which may include physical isolation from others, if the individual refuses to receive adequate chemotherapy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#B">B.</span> Control of Contacts. A health officer shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#B(1)">(1)</span> Direct that testing for tuberculosis infection using a Centers for Disease Control and Prevention approved method be performed on contacts of cases of tuberculosis in a communicable stage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#B(2)">(2)</span> Recommend appropriate treatment for latent tuberculosis infection; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.20#B(3)">(3)</span> Provide for the supervised presumptive treatment of latent tuberculosis infection for a child younger than 5 years old identified as a close contact to a confirmed case or suspected case of active pulmonary tuberculosis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.21" data-order="|10|06|01|.21|" data-ref-path="10|06|01|.21" class="h__section">.21 Typhoid Fever (Salmonella Typhi) and Paratyphoid Fever (Salmonella Paratyphi A, Salmonella Paratyphi B tartrate negative, and Salmonella Paratyphi C).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A">A.</span> Control of a Case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(1)">(1)</span> A case may not attend a child care facility until fecal specimens are Salmonella-free on three consecutive specimens collected not less than 24 hours apart and not sooner than 48 hours following discontinuation of antibiotics, or until a health officer approves readmission based on the low likelihood of transmission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(2)">(2)</span> A case may not participate in occupations involving food handling, patient care, or care of young children or the elderly until fecal specimens are Salmonella-free on three consecutive specimens collected not less than 24 hours apart, and not sooner than 48 hours after discontinuation of antibiotics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(3)">(3)</span> A health officer shall supervise a case and release a case from supervision only after fecal specimens are culture negative for Salmonella Typhi or Paratyphi on three consecutive specimens collected not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(3)(a)">(a)</span> Less than 24 hours apart;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(3)(b)">(b)</span> Sooner than 48 hours following discontinuation of antibiotics; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(3)(c)">(c)</span> Earlier than 1 month after onset or date of first positive culture if asymptomatic.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(4)">(4)</span> If any one of the specimens required in <a class="internal-link " href="/us/md/exec/comar/10.06.01.21#A(3)" title="">§A(3) of this regulation</a> is positive, at least three consecutive negative cultures of feces at intervals of 1 month within the 12 months following onset shall be required for release from supervision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#A(5)">(5)</span> If a person continues to excrete Salmonella Typhi or Paratyphi at 12 months, the requirements of <a class="internal-link " href="/us/md/exec/comar/10.06.01.21#D" title="">§D of this regulation</a> apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#B">B.</span> Control of Contacts of a Case. Household, sexual, and other close contacts of a case may not attend a child care facility or participate in occupations involving food handling, patient care, or care of young children or the elderly until two consecutive cultures of feces taken at least 24 hours apart are negative for Salmonella Typhi or Paratyphi.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#C">C.</span> Infection Control. A health care provider shall practice standard precautions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D">D.</span> Control of Carriers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)">(1)</span> A health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(a)">(a)</span> Monitor the location, occupation, and bacteriological status of a carrier of Salmonella Typhi or Paratyphi;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(b)">(b)</span> Keep a complete file of all pertinent data on the carrier;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(c)">(c)</span> Issue written instructions to the carrier concerning the restrictions upon and responsibilities of the carrier;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(d)">(d)</span> Notify the carrier of the availability of treatments that may eliminate carriage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(e)">(e)</span> Contact each carrier in the health officer's jurisdiction at intervals of not more than 1 year to check on the carrier's occupation and address and to determine if all instructions are being followed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(f)">(f)</span> Release a carrier from supervision only after there have been three consecutive negative cultures of feces, taken 1 month apart at least 48 hours after antibiotic treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(1)(g)">(g)</span> Forward immediately to the Secretary a report of a carrier who has relocated outside the health officer's territorial jurisdiction for referral to the health officer of the proper jurisdiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(2)">(2)</span> A case or a case's physician shall submit the fecal specimens to the State Laboratory for the release of a carrier.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)">(3)</span> A carrier:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(a)">(a)</span> May not participate in occupations involving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(a)(i)">(i)</span> Food handling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(a)(ii)">(ii)</span> Patient care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(a)(iii)">(iii)</span> Care of young children or the elderly;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(b)">(b)</span> Shall abide by Regulation .06D and E; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#D(3)(c)">(c)</span> Shall keep a health officer informed at all times of the carrier's address and occupation, and shall notify the health officer at once of any change in address or occupation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E">E.</span> Control of Contacts of a Carrier.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(1)">(1)</span> A health officer shall require culture of feces of those household and close contacts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(1)(a)">(a)</span> Who attend a child care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(1)(b)">(b)</span> Whose occupations involve:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(1)(b)(i)">(i)</span> Food handling; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(1)(b)(ii)">(ii)</span> Care of patients, young children, or the elderly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(2)">(2)</span> A contact shall submit for examination two fecal specimens taken at an interval of not less than 24 hours apart.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.21#E(3)">(3)</span> If either of the specimens required in <a class="internal-link " href="/us/md/exec/comar/10.06.01.21#E(2)" title="">§E(2) of this regulation</a> is positive for Salmonella Typhi or Paratyphi, then the health officer shall consider the contact to be a case, and the control measures specified in <a class="internal-link " href="/us/md/exec/comar/10.06.01.21#A" title="">§A of this regulation</a> apply.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.22" data-order="|10|06|01|.22|" data-ref-path="10|06|01|.22" class="h__section">.22 Sale and Distribution of Reptiles.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A">A.</span> Scope.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(1)">(1)</span> Pursuant to the authority conferred upon the Secretary by Health-General Article, §18-219, Annotated Code of Maryland, the Secretary has determined that reptiles and reptile eggs are dangerous to human health and safety in that human contact with reptiles and reptile eggs may spread disease to humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(2)">(2)</span> The Secretary prohibits the sale or public distribution of turtles with a carapace length of less than 4 inches and viable reptile eggs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(3)">(3)</span> The Secretary may permit the sale and public distribution of reptiles in accordance with specific requirements and conditions as stated in <a class="internal-link " href="/us/md/exec/comar/10.06.01.22#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)">(4)</span> This regulation does not apply to a turtle:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)(a)">(a)</span> Used for agricultural purposes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)(b)">(b)</span> Used for scientific purposes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)(c)">(c)</span> Used for educational purposes as certified by a health officer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)(d)">(d)</span> Used for public exhibitions; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(4)(e)">(e)</span> That the Secretary determines is not a threat to human health and safety.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(5)">(5)</span> The requirements of this regulation are in addition to any requirement imposed by <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gnr/gnr.pdf" title="">Natural Resources Article, Title 10, Subtitle 9, Annotated Code of Maryland</a>, and regulations adopted under it.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#A(6)">(6)</span> The giving away of reptiles is subject to the crimes and punishments set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=10-610" title="">Criminal Law Article, §10-610, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B">B.</span> Reptile Sales.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(1)">(1)</span> A person may not sell in Maryland viable reptile eggs or live turtles with a carapace length of less than 4 inches, except as otherwise provided in <a class="internal-link " href="/us/md/exec/comar/10.06.01.22#A(4)" title="">§A(4) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)">(2)</span> A person may sell turtles with a carapace length of 4 inches or more and other live reptiles in Maryland if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(a)">(a)</span> A caution notice with the text as indicated in <a class="internal-link " href="/us/md/exec/comar/10.06.01.22#C" title="">§C of this regulation</a> is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(a)(i)">(i)</span> Posted by the person selling reptiles;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(a)(ii)">(ii)</span> Posted within 3 feet of each display of reptiles; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(a)(iii)">(iii)</span> A minimum of 8 x 11 inches in size; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(b)">(b)</span> At the time of the sale of a reptile, the seller:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(b)(i)">(i)</span> Furnishes the buyer with a copy of the caution notice; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#B(2)(b)(ii)">(ii)</span> Has the buyer sign a log or statement that the buyer has read the caution notice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C">C.</span> Caution Notice. A person who sells reptiles shall post a caution notice that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C(1)">(1)</span> Is in 4 parts, each separated by a horizontal 4-point rule;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C(2)">(2)</span> In part 1 has the word "Caution" set in 100-point Times Roman Bold;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C(3)">(3)</span> In part 2 has the following paragraph set in 30-point Times Roman: "Reptiles and other pets may carry and transmit germs (including Salmonella) to humans. It is important to wash your hands thoroughly after handling reptiles and other pets or coming in contact with their water, food, housing material, or container. Do not allow pet water, food, or housing material to come in contact with your food or areas where food is prepared.";</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C(4)">(4)</span> In part 3 has the following sentence set in 42-point Times Roman Bold: "Provide your reptiles and other pets with a clean home, a suitable diet, and other proper care."; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#C(5)">(5)</span> In part 4 has the following sentence set in 30-point Times Roman: "If you or any member of your family is prone to or has serious health problems or is pregnant or your family includes a child younger than 5 years old, you should consult your physician before purchase."</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#D">D.</span> Penalties and Seizure of Contraband Reptiles.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#D(1)">(1)</span> Pursuant to Health-General Article, §§18-219 and 18-222, Annotated Code of Maryland, a person who imports, transports, sells, transfers, breeds, raises, keeps, or possesses any live turtle with a carapace length of less than 4 inches, other reptiles, or reptile eggs in violation of §§A—C of this regulation is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $500, or imprisonment not exceeding 1 year, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.22#D(2)">(2)</span> An authorized law enforcement officer may seize a turtle with a carapace length of less than 4 inches, viable turtle and other reptile eggs, and other reptiles, which are considered a nuisance and a contraband pursuant to Health-General Article, §18-222, Annotated Code of Maryland, and <a class="internal-link " href="/us/md/exec/comar/10.06.01.22#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.23" data-order="|10|06|01|.23|" data-ref-path="10|06|01|.23" class="h__section">.23 Communicable Disease Information Provided With Sale and Distribution of Pet Animals.</h3>
                <p>To help prevent the spread of a communicable disease, a seller or a group of sellers who prepares or causes to be prepared a pamphlet, flyer, or other printed information on the handling of one or more pet animals and who distributes the pamphlet, flyer, or other printed information, shall ensure that the pamphlet, flyer, or other printed information stresses the:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.23#A">A.</span> Importance of handwashing after contact with a reptile or other pet animals or its surroundings; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.23#B">B.</span> Need to consult a physician if one or more of the following individuals live in the household for which a pet animal is purchased:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.23#B(1)">(1)</span> A child younger than 5 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.23#B(2)">(2)</span> A pregnant woman; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.23#B(3)">(3)</span> An immunocompromised individual.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.01.24" data-order="|10|06|01|.24|" data-ref-path="10|06|01|.24" class="h__section">.24 Control of Communicable Diseases in Pet Stores.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#A">A.</span> A pet store shall utilize procedures to ensure prevention and control of diseases common to and shared among humans and animals.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#B">B.</span> To ensure prevention and control of diseases common to and shared among humans and animals, the Department recommends that pet stores utilize the Compendium of Animal Rabies Prevention and Control, the Compendium of Measures To Control Chlamydophila psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), and the Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, issued by the National Association of State Public Health Veterinarians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#C">C.</span> A health officer shall annually inspect a pet store to determine compliance with <a class="internal-link " href="/us/md/exec/comar/10.06.01.24#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#D">D.</span> A health officer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#D(1)">(1)</span> May delegate the authority to conduct annual pet store inspections to another specified agency such as, but not limited to, local animal control; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#D(2)">(2)</span> Shall execute and keep on file a written agreement with the delegated inspection agency.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#E">E.</span> Enforcement. An authorized law enforcement officer or local animal control authority shall promptly enforce a written order of a health officer or the Maryland Public Health Veterinarian issued pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02" title="Chapter 02 Communicable Diseases — Rabies">COMAR 10.06.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.01.24#F">F.</span> Penalty. The owner of a pet store refusing or failing to comply with the provisions of this regulation is subject to the penalties set forth in Health-General Article, §§18-222, 18-604, and 24-110, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.02" data-order="|10|06|02|" data-ref-path="10|06|02" class="h__chapter">Chapter 02 Communicable Diseases — Rabies</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 27, 1977 (4:9 Md. R. 714)</p>
                  <p>Preface and Regulation .01 recodified to Regulation .01 and Regulation .01-1, respectively, in July 1994</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.09#A" title="">Regulation .09A</a>, B amended effective February 14, 1994 (21:3 Md. R. 193)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.14" title=".14 Penalty.">.14</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.14" title=".14 Penalty.">.14</a> adopted effective November 16, 1998 (25:23 Md. R. 1696)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.01" title=".01 Scope.">Regulation .01</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.02#B" title="">Regulation .02B</a> amended as an emergency provision effective January 1, 2008 (35:3 Md. R. 286); emergency status extended at 35:9 Md. R. 892; amended permanently effective March 24, 2008 (35:6 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.02#B" title="">Regulation .02B</a> amended effective February 15, 2016 (43:3 Md. R. 272); February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.03#C" title="">Regulation .03C</a>, D amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.03#D" title="">Regulation .03D</a> amended effective May 20, 2019 (46:10 Md. R. 485)</p>
                  <p>Regulation .03E repealed effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.04" title=".04 Animal Rabies.">Regulation .04</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.04#B" title="">Regulation .04B</a>, D amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.06#E" title="">Regulation .06E</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.07" title=".07 Disposition of Animals Following Bite or Non-Bite Contact to Humans.">Regulation .07</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.09" title=".09 Laboratory Testing.">Regulation .09</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.10" title=".10 Vaccination of Animals.">Regulation .10</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.10#B" title="">Regulation .10B</a> amended as an emergency provision effective January 1, 2008 (35:3 Md. R. 286); emergency status extended at 35:9 Md. R. 892; amended permanently effective March 24, 2008 (35:6 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.11" title=".11 Importation of Animals.">Regulation .11</a> amended effective September 14, 2015 (42:18 Md. R. 1174)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.02.13#B" title="">Regulation .13B</a> amended effective September 14, 2015 (42:18 Md. R. 1174); February 27, 2017 (44:4 Md. R. 253)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§18-102, 18-312—18-320, and 18-604, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.02.01" data-order="|10|06|02|.01|" data-ref-path="10|06|02|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter provides for cooperative rabies control efforts by the Department, local health officers, physicians, veterinarians, and other Maryland government agencies as guided by policy statements such as the Compendium of Animal Rabies Prevention and Control, issued annually by the National Association of State Public Health Veterinarians.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.02" data-order="|10|06|02|.02|" data-ref-path="10|06|02|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(1)">(1)</span> "Adequately vaccinated" means a graduate veterinarian at a public antirabies clinic or a licensed veterinarian has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(1)(a)">(a)</span> Immunized an animal against rabies in accordance with the current year's recommendations as circulated by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(1)(b)">(b)</span> Documented the rabies immunization by issuing a valid rabies certificate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(2)">(2)</span> "Animal" means a nonhuman species of mammal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(3)">(3)</span> "Animal exposed to a rabid animal" means an animal that is known or is suspected to have had a bite from or non-bite contact with another animal that is known or suspected to be infected with rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(4)">(4)</span> "Apparently healthy" means an:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(4)(a)">(a)</span> Animal shows no signs of illness suggestive of rabies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(4)(b)">(b)</span> Investigation by the local health officer or the health officer’s designee shows that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(4)(b)(i)">(i)</span> The animal has not had a change in health or behavior in the past 30 calendar days, including but not limited to lethargy, lameness, weakness, slowness of movement or gait, paralysis, or loss of appetite; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(4)(b)(ii)">(ii)</span> A licensed veterinarian, having examined the animal more than 30 days before the bite or non-bite contact, has identified and documented that behavior or health changes were caused by a condition unrelated to rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(5)">(5)</span> "Area quarantine" means a geographic region designated by the Public Health Veterinarian within which animals of a species designated by the Public Health Veterinarian are subject to the restrictions specified in this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(6)">(6)</span> “Bite contact” means penetration of the skin by the teeth of an animal, regardless of whether blood is visible.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(7)">(7)</span> "Cat" means Felis catus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(8)">(8)</span> "Custodian" means a caretaker or keeper of an animal, or the local animal control authority who has responsibility for an unclaimed animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(9)">(9)</span> "Department" means the Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(10)">(10)</span> "Department-approved facility" means a facility that has prior written approval of the Department to quarantine rabies suspect animals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(11)">(11)</span> "Dog" means Canis familiaris, not including canine hybrids.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(12)">(12)</span> "Domestic animal" means a species of mammal that is accustomed to living in or about the habitation of man and is dependent on man for food or shelter, including but not limited to dogs, cats, ferrets, and livestock.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(13)">(13)</span> "Feral dog or cat" means a dog or cat that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(13)(a)">(a)</span> Shows no evidence, such as a collar, tag, or grooming, of being owned; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(13)(b)">(b)</span> Exhibits savage or wild behavior or is living in the wild.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(14)">(14)</span> "Ferret" means Mustela putorius furo.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(15)">(15)</span> “Livestock” means domestic farm animals, including but not limited to cattle, horses and other equines, swine, sheep, and goats.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(16)">(16)</span> "Local animal control authority" means that agency or individual appointed by the governing body of a county or the city of Baltimore to oversee animal control.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(17)">(17)</span> "Local health department" means a county health department under the direction of a local health officer or the Baltimore City Health Department under the direction of the Baltimore City Commissioner of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(18)">(18)</span> "Local health officer" means the local health officer of a county or the Baltimore City Commissioner of Health, or the designee of the local health officer or the Commissioner of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(19)">(19)</span> Non-Bite Contact.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(19)(a)">(a)</span> "Non-bite contact" means a scratch or contamination of an abrasion, open wound, or mucous membrane with saliva or other potentially infectious material from an animal.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(19)(b)">(b)</span> "Non-bite contact" does not include exposure to non-infectious material such as dried saliva.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(20)">(20)</span> "Person" means an individual, receiver, trustee, guardian, personal representative, fiduciary, or representative of any kind, and any partnership, firm, association, corporation, or other entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(21)">(21)</span> “Provoked” means that bite or non-bite contact from an animal resulted from human activity, such as an individual attempting to play with, pet, feed, handle, hold, harm, or redirect an animal’s actions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(22)">(22)</span> "Public Health Veterinarian" means the veterinarian designated by the Secretary as responsible for the Veterinary Public Health Program of the Department or the designee of the Public Health Veterinarian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(23)">(23)</span> "Quarantine" means, pursuant to an order of the Public Health Veterinarian or local health officer and on the private premises of the owner or custodian of the animal or at a Department-approved facility, confinement of an animal by leash, an escape-proof enclosure, or another manner, approved in writing by the Public Health Veterinarian or local health officer, that ensures protection of the public health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(24)">(24)</span> "Rabies" means an acute viral disease in humans and animals produced by a rhabdovirus belonging to the genus Lyssavirus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(25)">(25)</span> “Risk assessment” means the evaluation of the circumstances surrounding a bite or non-bite contact to determine the likelihood that an individual has been exposed to material potentially infectious with rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(26)">(26)</span> "Secretary" means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(27)">(27)</span> “Serologic monitoring” means monitoring of a dog or cat that was previously vaccinated against rabies to see if the animal demonstrates sufficient evidence of an immune response within seven days of being vaccinated against rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(28)">(28)</span> "State Epidemiologist" means the person designated as the State Epidemiologist by the Secretary or the designee of the State Epidemiologist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(29)">(29)</span> “Strict quarantine” means that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(29)(a)">(a)</span> An animal is confined in an escape-proof enclosure that precludes direct contact with people and other animals;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(29)(b)">(b)</span> The animal is not removed from the enclosure at any time except for transport in a manner, approved in writing by the local health officer, that will safeguard the public health;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(29)(c)">(c)</span> Human contact with the animal is restricted to one adult caring for the animal or not allowed at all by the local health officer or Public Health Veterinarian; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(29)(d)">(d)</span> The owner or custodian of the animal has signed an agreement with the local health department or animal control authority that the owner or custodian has met and agrees to meet the requirements specified in §B(28)(a)—(c) of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(30)">(30)</span> "Unclaimed stray animal" means a domestic animal that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(30)(a)">(a)</span> Not a feral dog or cat; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(30)(b)">(b)</span> Unclaimed by an owner after being held by the local animal control authority at least 72 hours for an owner to claim it.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(31)">(31)</span> "Wild animal" means a member of a mammalian species that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(31)(a)">(a)</span> Not a domestic animal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(31)(b)">(b)</span> A feral dog or cat; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.02#B(31)(c)">(c)</span> An unclaimed stray animal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.03" data-order="|10|06|02|.03|" data-ref-path="10|06|02|.03" class="h__section">.03 Human Rabies.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#A">A.</span> Reporting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#A(1)">(1)</span> A physician, medical authority, or another person having knowledge of or suspicion of a case of human rabies shall immediately report the facts to the local health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#A(2)">(2)</span> A local health officer who has received a report of a case or suspected case of human rabies shall immediately notify, by telephone or other immediate communication medium, the State Epidemiologist or the Public Health Veterinarian of the case or suspected case.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#B">B.</span> Isolation. A physician or administrator of a health care facility providing medical care to an individual who is suspected of having been infected with rabies shall isolate the individual in accordance with the order of a local health officer or the State Epidemiologist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C">C.</span> Immunization; Preexposure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(1)">(1)</span> The Department shall provide rabies vaccine free of charge and the local health officer shall provide for the administration of preexposure immunization against rabies for any employee of the Department, a local health department, or another individual who provides rabies control services at the request of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(2)">(2)</span> The local health officer may provide rabies preexposure immunization to other individuals who are determined by the Public Health Veterinarian to have a high risk of exposure to rabies infection.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(3)">(3)</span> The local health officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(3)(a)">(a)</span> Report to the Public Health Veterinarian at least every 3 months, the number of preexposure immunizations administered; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(3)(b)">(b)</span> Maintain records of the name, address, age, sex, county of residence, occupation, and the results of any blood tests administered in conjunction with rabies preexposure immunization for each individual immunized.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(4)">(4)</span> The Public Health Veterinarian and the State Epidemiologist shall make and distribute to local health officers recommendations on the dose and schedule of administration of rabies vaccine for the purpose of preexposure immunization of individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#C(5)">(5)</span> The local health officer shall administer rabies preexposure immunizations according to the recommendations developed by the Public Health Veterinarian and the State Epidemiologist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D">D.</span> Treatment; Postexposure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(1)">(1)</span> The Public Health Veterinarian and the State Epidemiologist shall jointly issue and distribute to local health departments, physicians, hospitals, and other medical authorities, rabies postexposure treatment guidelines.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)">(2)</span> A local health officer shall report to the Public Health Veterinarian:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(a)">(a)</span> At least every 3 months, the number of postexposure treatments administered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)">(b)</span> At the completion of treatment, for each individual administered treatment, the individual’s:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(iii)">(iii)</span> Age;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(iv)">(iv)</span> Sex;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(v)">(v)</span> County of residence; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(b)(vi)">(vi)</span> Occupation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(2)(c)">(c)</span> Other information as directed by the Public Health Veterinarian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(3)">(3)</span> The Department shall ensure no one is denied rabies postexposure treatment due to the inability to pay when the treatment is provided in accordance with the guidelines issued by the Public Health Veterinarian and the State Epidemiologist and recommended by a licensed health care provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(4)">(4)</span> The local health officer of the jurisdiction where the resident resides shall ensure access to rabies postexposure treatment provided in accordance with the guidelines issued by the Public Health Veterinarian and the State Epidemiologist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(5)">(5)</span> When rabies postexposure treatment is provided in accordance with the guidelines issued by the Public Health Veterinarian and the State Epidemiologist, the Department shall pay the charge of the rabies biologics for persons unable to pay for them:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(5)(a)">(a)</span> Based on the current ability-to-pay schedule of the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.03#D(5)(b)">(b)</span> Only after all available benefits and discounts are applied.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.04" data-order="|10|06|02|.04|" data-ref-path="10|06|02|.04" class="h__section">.04 Animal Rabies.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#A">A.</span> Reporting. An individual shall report immediately by telephone or in person to the local police, sheriff’s department, or local animal control authority if they know of an animal that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#A(1)">(1)</span> Has rabies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#A(2)">(2)</span> Is suspected of having rabies; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#A(3)">(3)</span> Has had a bite from or non-bite contact with an animal known to have or suspected of having rabies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B">B.</span> Disposition of a Suspected Rabid Animal — No Bite or Non-Bite Human Contact.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)">(1)</span> Dogs, Cats, and Ferrets.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)(a)">(a)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.02.04#B(3)" title="">§B(3) of this regulation</a>, the director of a Department-approved facility shall hold in strict quarantine, in a manner and place as established by the local health officer or the Public Health Veterinarian, any dog, cat, or ferret suspected of having rabies that has not had bite or non-bite contact with an individual in the preceding 10 days.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)(b)">(b)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.02.04#B(3)" title="">§B(3) of this regulation</a>, unless otherwise specified by the Public Health Veterinarian, the director of a Department-approved facility shall continue the strict quarantine of the suspected rabid animal for at least 10 days and maintain proper, humane care of the animal during the period of strict quarantine, after which the animal may be humanely killed or released to its owner or custodian or for adoption.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)(c)">(c)</span> At any time during the strict quarantine period, the local health officer, the Public Health Veterinarian, the owner, or the custodian of the animal may direct that the animal suspected of having rabies be humanely killed for the purpose of rabies testing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)(d)">(d)</span> At any time during the strict quarantine period, the owner or custodian of the animal may direct that the animal be humanely killed.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(1)(e)">(e)</span> Rabies testing is not required if there is no human contact or contact with another animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(2)">(2)</span> Livestock.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(2)(a)">(a)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.02.04#B(3)" title="">§B(3) of this regulation</a>, the Public Health Veterinarian shall direct the owner or custodian of livestock that has not had bite or non-bite contact with an individual and is suspected of having rabies to hold the livestock in strict quarantine for at least 10 days and shall designate the place and manner in which the strict quarantine is to be carried out, after which the livestock may be humanely killed or released to the owner or custodian.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(2)(b)">(b)</span> At any time during the strict quarantine period, the local health officer, the Public Health Veterinarian, the owner, or the custodian of the animal may direct that the animal be humanely killed for the purpose of rabies testing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(2)(c)">(c)</span> At any time during the strict quarantine period, the owner or custodian of the animal may direct that the animal be humanely killed.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(2)(d)">(d)</span> Rabies testing is not required if there is no human contact or contact with another animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(3)">(3)</span> Wild Animals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(3)(a)">(a)</span> The local health officer or Public Health Veterinarian may order a wild animal that is suspected of having rabies to be humanely killed if there is no evidence that the animal has an individual owner.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(3)(b)">(b)</span> If there is evidence of ownership, the Public Health Veterinarian, local health officer, or local animal control authority may order the humane killing of the animal if the owner or custodian does not appear within 24 hours to claim the animal or if there is imminent threat to human health or safety. For unclaimed stray animals, the 24-hour period is included within the period required under <a class="internal-link " href="/us/md/exec/comar/10.06.02.02#B(29)" title="">Regulation .02B(29) of this chapter</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(3)(c)">(c)</span> If an owner or custodian of the wild animal claims the animal within 24 hours, the Public Health Veterinarian may order the owner to hold the animal in strict quarantine in a place and manner determined by the Public Health Veterinarian for at least 30 days, after which it may be released to the owner or custodian if the animal has not developed rabies.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#B(3)(d)">(d)</span> At any time during the strict quarantine period, the local health officer, the Public Health Veterinarian, or the owner or custodian of the animal may direct that the animal be humanely killed for the purpose of rabies testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#C">C.</span> Examination of Animals Suspected of Having Rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#C(1)">(1)</span> The Public Health Veterinarian or the local health officer may order a veterinary examination at any time of an animal suspected of having rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#C(2)">(2)</span> The examining veterinarian shall report the results of the examination to the local health officer immediately.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#C(3)">(3)</span> The owner or custodian of the animal shall bear the expense of the examination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D">D.</span> Disposition of an Animal Exposed to a Rabid Animal or to an Animal Suspected of Having Rabies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(1)">(1)</span> If the owner or custodian of a domestic animal that has been exposed to a rabid animal, or to an animal suspected of having rabies, is able to provide a current or expired rabies vaccination certificate for the animal, the owner or custodian shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(1)(a)">(a)</span> Have the animal re-vaccinated against rabies immediately; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(1)(b)">(b)</span> Keep the animal under the owner or custodian’s control and observed for 45 calendar days or for such time as specified by the Public Health Veterinarian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(2)">(2)</span> If the owner or custodian of a domestic animal that has been exposed to a rabid animal, or to an animal suspected of having rabies, is unable to provide a current or expired rabies vaccination certificate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(2)(a)">(a)</span> The owner or custodian shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(2)(a)(i)">(i)</span> Have the animal humanely killed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(2)(a)(ii)">(ii)</span> Have the animal vaccinated against rabies immediately, and hold dogs and cats in strict quarantine for a minimum of 4 months and other animals in strict quarantine for a minimum of 6 months in a facility and a manner approved by the Public Health Veterinarian; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(2)(b)">(b)</span> The local health officer or animal control authority may consult with the Public Health Veterinarian to determine if serologic monitoring can be used to keep a dog or cat under the owner or custodian’s control and observed for 45 calendar days rather than under strict quarantine for 4 months if the owner or custodian of a dog or cat states that the dog or cat was previously vaccinated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(3)">(3)</span> The owner or custodian of a domestic animal that is being held in strict quarantine is responsible for all costs related to strict quarantine of the animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(4)">(4)</span> The local health officer, the Public Health Veterinarian, or the local animal control authority may make inspections of the site where an animal is being held in strict quarantine to assure that the animal is being held in strict quarantine under the terms specified in this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)">(5)</span> The local health officer or the Public Health Veterinarian may order the humane killing for rabies testing of an animal exposed to a rabid animal or to an animal suspected of having rabies if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(a)">(a)</span> The strict quarantine agreement defined in <a class="internal-link " href="/us/md/exec/comar/10.06.02.02#B(28)" title="">Regulation .02B(28) of this chapter</a> is violated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(b)">(b)</span> The animal shows signs of having developed rabies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(c)">(c)</span> A bite or non-bite contact to a human occurs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(d)">(d)</span> A bite or non-bite contact to another animal occurs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(e)">(e)</span> The animal is a wild animal; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.04#D(5)(f)">(f)</span> The exposed animal poses an imminent threat to human health or safety.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.05" data-order="|10|06|02|.05|" data-ref-path="10|06|02|.05" class="h__section">.05 Reporting Bite or Non-Bite Contacts to Humans.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#A">A.</span> A person having knowledge of an individual's having a bite from or non-bite contact with an animal shall report the facts of the contact immediately by telephone or in person to the local police or sheriff's department, except in Frederick County, where the person shall report the facts to the animal control center of Frederick County.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#B">B.</span> Except as provided at <a class="internal-link " href="/us/md/exec/comar/10.06.02.05#C" title="">§C of this regulation</a>, upon receipt of a report, the local police or sheriff's department or animal control personnel shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#B(1)">(1)</span> Complete the Maryland Animal-Bite Report and Rabies Quarantine Agreement Form supplied by the Department, or an equivalent form developed by the local health department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#B(2)">(2)</span> Make the report available within 24 hours to the local health officer and, on request, to the Public Health Veterinarian; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#B(3)">(3)</span> Enforce all orders of the local health officer and the Public Health Veterinarian pursuant to this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.05#C">C.</span> The local health officer shall report the number of animal bite and non-bite contacts to the Public Health Veterinarian monthly as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01" title="Chapter 01 Communicable Diseases and Related Conditions of Public Health Importance">COMAR 10.06.01</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.06" data-order="|10|06|02|.06|" data-ref-path="10|06|02|.06" class="h__section">.06 Risk Assessment Following Bite or Non-Bite Contact to Humans.</h3>
                <p>Following the report of a bite or non-bite contact to a human, the local health officer shall conduct a risk assessment that includes a determination of:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#A">A.</span> The species of animal that made the contact;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#B">B.</span> Whether the animal is apparently healthy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#C">C.</span> Whether the animal is adequately vaccinated appropriate to its age;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#D">D.</span> The type of contact;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#E">E.</span> Whether the bite or non-bite contact was provoked and what human activity may have provoked the bite or non-bite; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.06#F">F.</span> The reasonable likelihood that the contact animal may have rabies or may have been exposed to rabies within the past 6 months, including information about unsupervised out-of-doors escape episodes, injuries, and other potential contacts of the animal to wild animals or bats.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.07" data-order="|10|06|02|.07|" data-ref-path="10|06|02|.07" class="h__section">.07 Disposition of Animals Following Bite or Non-Bite Contact to Humans.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#A">A.</span> When the local health officer has determined that quarantine of the exposing animal is allowable based on the findings of the risk assessment, the animal shall be quarantined.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B">B.</span> Quarantine Period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(1)">(1)</span> Dogs, Cats, and Ferrets, Including Unclaimed Stray Animals. Except as provided in §B(3) and (4) of this regulation, the owner or custodian of a dog, cat, or ferret that was involved in bite or non-bite contact with a human shall quarantine the animal in a place and manner approved by the local health officer or the Public Health Veterinarian for at least 10 days after the date of the bite or contact.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(2)">(2)</span> Livestock Including Unclaimed Stray Animals. Except as provided in §B(3) and (4) of this regulation, the owner or custodian of livestock that has been involved in bite or non-bite contact with an individual shall quarantine the livestock in a place and manner approved by the Public Health Veterinarian in consultation with the Maryland Department of Agriculture for at least 10 days after the date of the bite or contact or a time period specified by the Public Health Veterinarian.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(3)">(3)</span> Wild Animals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(3)(a)">(a)</span> Except in situations in which the local health officer or the Public Health Veterinarian determines that an animal poses an imminent threat to public health or safety and must be killed immediately, the Public Health Veterinarian may order a wild animal involved in bite or non-bite contact with an individual to be placed in quarantine for at least 24 hours.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(3)(b)">(b)</span> If the animal is not claimed by an owner or custodian within that 24-hour period, the Public Health Veterinarian may order the animal to be humanely killed and its head submitted to the laboratory designated by the Department for rabies testing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(3)(c)">(c)</span> For unclaimed stray animals, the 24-hour period is included within the period required under <a class="internal-link " href="/us/md/exec/comar/10.06.02.02#B(29)" title="">Regulation .02B(29) of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#B(4)">(4)</span> Wild Animal with a Legal Owner. When a legally owned wild animal has been involved in bite or a non-bite contact with a human, the local health officer, in consultation with the Public Health Veterinarian, shall determine the disposition of the wild animal based on its individual risk assessment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#C">C.</span> Conditions of Quarantine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#C(1)">(1)</span> The Public Health Veterinarian or the local health officer may order the owner or custodian of an animal under quarantine that has had bite or non-bite contact with a human to have the animal examined by a Maryland-licensed veterinarian at any time during the quarantine period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#C(2)">(2)</span> The owner or custodian of an animal under quarantine shall pay for the cost of the veterinary examination and other associated costs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#C(3)">(3)</span> If a Maryland-licensed veterinarian determines that a quarantined animal has possible rabies manifestations, the veterinarian may humanely kill the animal and submit its head promptly through the local health officer or local animal control authority to the laboratory designated by the Department for testing for rabies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#D">D.</span> Limitation on Movement During Quarantine. A person may not move an animal under quarantine from the place of quarantine without the written permission of the local health officer or the Public Health Veterinarian.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#E">E.</span> Humane Killing of an Animal for Rabies Testing. The local health officer or the Public Health Veterinarian may order in writing the humane killing of an animal that has had bite or non-bite contact with a human for the purpose of rabies testing if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#E(1)">(1)</span> The local health officer has determined that the contact animal is reasonably likely to have rabies based on the risk assessment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#E(2)">(2)</span> The owner or custodian requests humane destruction during the quarantine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#E(3)">(3)</span> The animal is a wild animal unclaimed for at least 24 hours by an owner or custodian, with, for unclaimed stray animals, the 24-hour period included within the period required under <a class="internal-link " href="/us/md/exec/comar/10.06.02.02#B(29)" title="">Regulation .02B(29) of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#E(4)">(4)</span> The animal is inhumanely suffering.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#F">F.</span> Surrender of Animals. A person may not fail or refuse to surrender a dead or live animal for quarantine, humane killing, or rabies testing as required in this chapter when demand is made by written order of the local health officer or the Public Health Veterinarian.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.07#G">G.</span> The police, sheriff, or animal control authority staff shall enforce all written orders of the local health officer or Public Health Veterinarian issued pursuant to this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.08" data-order="|10|06|02|.08|" data-ref-path="10|06|02|.08" class="h__section">.08 Area Quarantine.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.08#A">A.</span> If rabies is known to exist within an area, the Public Health Veterinarian, in conjunction with the Maryland Department of Agriculture, may establish an area quarantine for rabies, define the boundaries of the quarantine area, and specify the species of animal or animals subject to the quarantine.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.08#B">B.</span> The owner or custodian of an animal subject to the area quarantine shall keep the animal in quarantine on the premises of the owner or custodian at all times until the area quarantine is terminated in writing by the Public Health Veterinarian, in conjunction with the Maryland Department of Agriculture.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.08#C">C.</span> A person may not bring an animal subject to an area quarantine into or out of the quarantine area without the written permission of the Public Health Veterinarian and the Department of Agriculture.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.09" data-order="|10|06|02|.09|" data-ref-path="10|06|02|.09" class="h__section">.09 Laboratory Testing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#A">A.</span> A local health officer or local animal control authority shall submit rabies specimens for laboratory testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#B">B.</span> The director of the rabies testing laboratory shall promptly forward a copy of the results of a rabies examination to the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#B(1)">(1)</span> Local health officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#B(2)">(2)</span> Individual that originally submitted the specimen to the laboratory from the local animal control authority; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#B(3)">(3)</span> Public Health Veterinarian.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#C">C.</span> The director of the rabies testing laboratory shall promptly report by telephone to the local health officer a positive rabies finding on a specimen from an animal that has been involved in bite or non-bite contact with an individual.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.09#D">D.</span> After receiving results of a positive finding of rabies, the local health officer shall notify the attending physician or attending veterinarian by telephone.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.10" data-order="|10|06|02|.10|" data-ref-path="10|06|02|.10" class="h__section">.10 Vaccination of Animals.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#A">A.</span> An owner or custodian of a dog, cat, or ferret shall have that animal adequately vaccinated against rabies by the time the dog, cat, or ferret is 4 months old.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B">B.</span> Vaccination Documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B(1)">(1)</span> Except for a local animal control authority, an owner or custodian of an animal required to be licensed or registered shall have the animal adequately vaccinated and shall obtain a valid rabies vaccination certificate on the form specified by the Department. The certificate shall be completed and signed by a Maryland-licensed veterinarian or, in the case of public antirabies clinics, the certificate may be issued under the authority of the Public Health Veterinarian, documenting that the animal has been adequately vaccinated against rabies for the period of time covered by the rabies vaccination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B(2)">(2)</span> Except for a kennel licensed by the local animal control authority as a boarding kennel, an owner or operator of a kennel shall present, upon the request of the local health officer, Public Health Veterinarian, or local animal control authority, a valid rabies vaccination certificate for each dog, cat, or ferret:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B(2)(a)">(a)</span> Owned or kept by the kennel; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B(2)(b)">(b)</span> That is 4 months old or older.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#B(3)">(3)</span> The Public Health Veterinarian may delay temporarily or indefinitely the rabies vaccination requirement for certain dogs, cats, or ferrets in the interest of public safety or for medical determinations or research.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#C">C.</span> Unless the Public Health Veterinarian has authorized a delay in vaccination, a local animal control authority may not license or register a dog, cat, or ferret without verifying the rabies vaccination status as documented by a current rabies vaccination certificate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D">D.</span> Vaccination Certificates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(1)">(1)</span> A vaccine manufacturer shall issue the official National Association of State Public Health Veterinarians (NASPHV) Form 51, Rabies Vaccination Certificate, or an equivalent form.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(2)">(2)</span> A veterinarian shall administer rabies vaccine to an animal in accordance with the specifications on the vaccine and recommendations for immunization procedures, such as the current Compendium of Animal Rabies Prevention and Control.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)">(3)</span> The veterinarian administering rabies vaccine to an animal shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)">(a)</span> Complete the NASPHV Form 51, or an equivalent form, containing the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(i)">(i)</span> Vaccine manufacturer and lot or serial number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(ii)">(ii)</span> Date the vaccine was given;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(iii)">(iii)</span> Date the next vaccination is due by;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(iv)">(iv)</span> Signature of the veterinarian and the date the rabies certificate was signed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(v)">(v)</span> Veterinarian’s name, address, telephone number, and veterinary license number legibly stamped, typed, or printed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(vi)">(vi)</span> Owner’s name, address, and telephone number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(vii)">(vii)</span> Rabies tag number; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(3)(a)(viii)">(viii)</span> Animal’s species, age, weight, predominant breed, and color; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(4)">(4)</span> When vaccine is administered at public antirabies clinics, the local clinic staff shall complete the NASPHV Form 51, or an equivalent form, as directed by the Public Health Veterinarian and provide a copy to the local health officer and the animal owner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(5)">(5)</span> A veterinarian administering rabies vaccine shall maintain copies of vaccination certificates by tag number for a minimum of 5 years following the vaccination of an animal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#D(6)">(6)</span> An owner or custodian may use the vaccination certificate as proof of vaccination and shall provide it to police, the animal control authority, or health officials upon request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E">E.</span> Vaccination Procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E(1)">(1)</span> A licensed veterinarian may select a rabies vaccine of the veterinarian’s choice and use procedures for administering it that are consistent with the recommendations of NASPHV, the United States Department of Agriculture, and the Compendium of Animal Rabies Prevention and Control.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E(2)">(2)</span> The Public Health Veterinarian shall select the vaccine or vaccines to be used in public clinics according to Department procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E(3)">(3)</span> The Public Health Veterinarian may require specified lots of vaccine to be tested for potency, safety, and contamination as a prerequisite to their use.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E(4)">(4)</span> Except for veterinary staffing, the public antirabies clinics and the local health officer shall determine all administrative procedures for public antirabies clinics in keeping with the requirements of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#E(5)">(5)</span> A vendor of rabies vaccine for animal use shall supply vaccine only to a veterinary biologic supply firm, a Maryland-licensed veterinarian, or the Public Health Veterinarian.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#F">F.</span> Rabies Tags.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#F(1)">(1)</span> The Public Health Veterinarian shall specify annually the size, shape, and color of the rabies tag to be issued by veterinarians and public antirabies clinics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#F(2)">(2)</span> Public antirabies clinics and veterinarians who provide rabies vaccination services to dogs, cats, and ferrets shall promptly issue to the owner of each vaccinated animal a rabies certificate, tag, and s-shaped metal link for attaching the tag on the animal's collar.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#F(3)">(3)</span> The local health officer shall order rabies tags through the Public Health Veterinarian for use in public antirabies clinics.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G">G.</span> Antirabies Clinics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G(1)">(1)</span> In conjunction with the Department, each local health department shall provide for low-cost, self-financing, antirabies clinics for animals in each county and Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G(2)">(2)</span> The Department shall assure that at least two clinics are offered annually with at least one to be held between April 1 and July 1 at dates and locations determined by the local health department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G(3)">(3)</span> The Public Health Veterinarian shall establish in writing the vaccination procedures to be used at the clinics and distribute these procedures to the local health officers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G(4)">(4)</span> The local health departments may establish fees sufficient to cover the costs of operating the clinics.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.10#G(5)">(5)</span> The local health officer shall report, in the manner specified by the Public Health Veterinarian, data concerning animals vaccinated at each clinic and the related costs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.11" data-order="|10|06|02|.11|" data-ref-path="10|06|02|.11" class="h__section">.11 Importation of Animals.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A">A.</span> Except as provided in §§B and I of this regulation, the owner or custodian of a dog, cat, or ferret 4 months old or older to be imported into the State for any purpose shall forward a certificate, issued by a licensed veterinarian, to the Public Health Veterinarian, within 10 days of the animal's arrival in the State, that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A(1)">(1)</span> Describes the dog, cat, or ferret, documenting that it was vaccinated against rabies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A(2)">(2)</span> Lists the manufacturer or brand of vaccine used;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A(3)">(3)</span> Lists the date or dates the vaccine was given;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A(4)">(4)</span> Documents that the animal is adequately vaccinated; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#A(5)">(5)</span> Documents that the most recent dose of vaccine was given more than 30 days before the date the animal arrived in the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#B">B.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.02.11#I" title="">§I of this regulation</a>, the owner or custodian of a dog, cat, or ferret brought into the State for a period of less than 30 days is exempt from the requirement to forward a certificate to the Public Health Veterinarian as specified in <a class="internal-link " href="/us/md/exec/comar/10.06.02.11#A" title="">§A of this regulation</a>, if a copy of a certificate signed by a licensed veterinarian can be presented to the local health officer immediately when requested.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#C">C.</span> The local animal control authority may accept the certificate specified in <a class="internal-link " href="/us/md/exec/comar/10.06.02.11#A" title="">§A of this regulation</a> as proof of vaccination for licensing or registration purposes for the period specified on the certificate or 12 months, whichever period is shorter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#D">D.</span> The Public Health Veterinarian or the local health officer may order the owner or custodian of a dog, cat, or ferret brought into Maryland in violation of the provisions of this regulation to return the animal immediately to its point of origin at the owner's expense.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#E">E.</span> If the local animal control authority is unable to locate an individual who will assume fiscal responsibility for an animal under an order to be returned to the point of origin within 48 hours of the issuance of the order, the authority may deem the animal abandoned and humanely kill it or place it for adoption.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#F">F.</span> Research facilities and licensed dealers, as defined in 7 U.S.C. §2132 and 9 CFR 1.1 and 2.7, are exempt from §§D and E of this regulation when importing dogs, cats, and ferrets.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#G">G.</span> The Secretary shall establish, in consultation with the Maryland Department of Agriculture, rabies control requirements for the importing and keeping of animals other than dogs, cats, and ferrets, such as livestock, wildlife, zoo animals, and exotic animals.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#H">H.</span> The Secretary, with the agreement of the Secretary of Agriculture and the Secretary of Natural Resources, shall prohibit the importation of certain animals or species of animals from areas inside or outside the United States that are known to have a high prevalence of rabies and the animals subject to the ban are judged to present an unacceptable risk of rabies infection in humans or animals.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.11#I">I.</span> The Public Health Veterinarian may waive the requirements of §§A and B of this regulation if the importation of the animal poses no risk to the public health or safety.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.12" data-order="|10|06|02|.12|" data-ref-path="10|06|02|.12" class="h__section">.12 Permits Required for Keeping Certain Animals.</h3>
                <p>The Secretary shall require a person to obtain from the Public Health Veterinarian a permit for keeping certain animals or species of animals if the Secretary has determined that these animals or species of animals represent a substantial threat of rabies to humans.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.13" data-order="|10|06|02|.13|" data-ref-path="10|06|02|.13" class="h__section">.13 Disposition of Animals by Animal Shelters, Pounds, or Veterinarians.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#A">A.</span> The owner or custodian of an animal who surrenders the animal to an animal shelter, pound, or veterinarian for the purpose of having the animal humanely killed or for the purpose of offering the animal for adoption shall certify in writing, under penalty of perjury, that the animal:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#A(1)">(1)</span> If a dog, cat, ferret, or livestock, has not had bite or non-bite contact with an individual within the previous 10 days; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#A(2)">(2)</span> If a wild animal, has not had bite or non-bite contact with an individual within the previous 30 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#B">B.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.02.13#C" title="">§C of this regulation</a>, if the animal has had bite or non-bite contact with an individual within the time periods specified in <a class="internal-link " href="/us/md/exec/comar/10.06.02.13#A" title="">§A of this regulation</a>, the animal shelter, pound, or veterinarian shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#B(1)">(1)</span> If the animal is a dog, cat, ferret, or livestock, offer the owner or custodian, the option of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#B(1)(a)">(a)</span> Quarantining the animal for 10 calendar days at the owner’s or custodian’s expense; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#B(1)(b)">(b)</span> Humanely killing the animal and submitting the head for rabies testing; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#B(2)">(2)</span> If the animal is a wild animal, immediately humanely kill the animal and submit its head for rabies testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.02.13#C">C.</span> The Public Health Veterinarian may waive the requirements of <a class="internal-link " href="/us/md/exec/comar/10.06.02.13#B" title="">§B of this regulation</a> if it is determined that the public health is not threatened.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.02.14" data-order="|10|06|02|.14|" data-ref-path="10|06|02|.14" class="h__section">.14 Penalty.</h3>
                <p>A person refusing or failing to comply with the provisions of this chapter, or with the orders or directives of the local health officer, the State Epidemiologist, or the Public Health Veterinarian as provided by this chapter, shall be guilty of a misdemeanor and, upon conviction, subject to a fine of not more than $500 for each offense.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.03" data-order="|10|06|03|" data-ref-path="10|06|03" class="h__chapter">Chapter 03 ImmuNet</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 27, 2015 (42:8 Md. R. 607)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §18-109; <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.03.01" data-order="|10|06|03|.01|" data-ref-path="10|06|03|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter governs ImmuNet, a computer-based registry of immunizations, as established in Health-General Article, §18-109, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.02" data-order="|10|06|03|.02|" data-ref-path="10|06|03|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)">(1)</span> “Authorized user” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(a)">(a)</span> A child care facility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(b)">(b)</span> A health care provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(c)">(c)</span> A health insurer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(d)">(d)</span> A health maintenance organization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(e)">(e)</span> An institution of higher learning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(f)">(f)</span> A local health department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(g)">(g)</span> A long-term care facility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(h)">(h)</span> A managed care organization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(i)">(i)</span> A nonprofit health service plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(j)">(j)</span> A patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(k)">(k)</span> A pharmacist authorized to administer vaccinations in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(l)">(l)</span> A school;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(m)">(m)</span> A school-based health center;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(n)">(n)</span> In the case of a minor child, a parent or guardian; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(1)(o)">(o)</span> Any other authorized user designated by the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(2)">(2)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(3)">(3)</span> “ImmuNet” means a computerized information and reminder system to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(3)(a)">(a)</span> Improve the timely and appropriate delivery of immunizations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(3)(b)">(b)</span> Provide a coordinated network for reminder notices when immunizations are due;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(3)(c)">(c)</span> Provide and collect information to be shared by authorized users; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(3)(d)">(d)</span> Provide a quality indicator for the insurers’ health care provider practices and public health purposes.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(4)">(4)</span> “Refusal to permit disclosure of information” means the right of an individual or the parent or guardian of a minor to prevent disclosure to authorized users of individual identifiable information that was reported to ImmuNet.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(5)">(5)</span> Regional Registry.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(5)(a)">(a)</span> “Regional registry” means a database that contains immunization information for individuals residing in an area of Maryland.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(5)(b)">(b)</span> “Regional registry” includes an immunization database or registry maintained and operated by a local health department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(6)">(6)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)">(7)</span> “Vaccine information statement (VIS)” means a document that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)(a)">(a)</span> Is created and updated by the U.S. Centers for Disease Control and Prevention; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)(b)">(b)</span> Relates:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)(b)(i)">(i)</span> The purpose of specific vaccines;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)(b)(ii)">(ii)</span> Schedules of administration; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.03.02#B(7)(b)(iii)">(iii)</span> Possible adverse reactions to specific vaccines.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.03" data-order="|10|06|03|.03|" data-ref-path="10|06|03|.03" class="h__section">.03 Administration of ImmuNet.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#A">A.</span> The Department shall support and administer ImmuNet.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#B">B.</span> The Department may enter or edit information contained in ImmuNet.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#C">C.</span> ImmuNet is subject to the security and reliability standards set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.03.09" title=".09 Security and Reliability Standards.">Regulation .09 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#D">D.</span> The Department shall make available to authorized users and to the general public all forms relevant to ImmuNet, such as the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#D(1)">(1)</span> User agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#D(2)">(2)</span> Refusal to Permit Disclosure of Information form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.03#D(3)">(3)</span> Statement of Reactivation of Participation in ImmuNet form.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.04" data-order="|10|06|03|.04|" data-ref-path="10|06|03|.04" class="h__section">.04 Information Reported to ImmuNet.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A">A.</span> The Department shall enter the following information from each birth certificate registered in Maryland:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(1)">(1)</span> Child’s:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(1)(a)">(a)</span> First, middle, and last name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(1)(b)">(b)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(1)(c)">(c)</span> Sex; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(1)(d)">(d)</span> Current or last known address; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(2)">(2)</span> Child’s mother’s:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(2)(a)">(a)</span> First and middle names;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(2)(b)">(b)</span> Maiden Name if applicable; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#A(2)(c)">(c)</span> Current last name.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B">B.</span> Following the administration of a vaccine to an individual residing in Maryland, the health care provider who administered the vaccine may enter the following information to ImmuNet:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)">(1)</span> Patient’s:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(a)">(a)</span> First, middle, and last name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(b)">(b)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(c)">(c)</span> Sex;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(d)">(d)</span> Birth state and country;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(e)">(e)</span> Current or last known address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(f)">(f)</span> If the patient is a minor, the name of the parent or guardian;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(g)">(g)</span> Last four digits of Social Security number, if available; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(1)(h)">(h)</span> Medicaid number, if available and applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(2)">(2)</span> Patient’s mother’s:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(2)(a)">(a)</span> First and middle names;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(2)(b)">(b)</span> Maiden name, if applicable; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(2)(c)">(c)</span> Current last name;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)">(3)</span> For each vaccine administered:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(a)">(a)</span> Antigen type;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(b)">(b)</span> Manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(c)">(c)</span> Expiration date;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(d)">(d)</span> Lot number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(e)">(e)</span> Date VIS provided to patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(f)">(f)</span> VIS date; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(3)(g)">(g)</span> Date of administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(4)">(4)</span> Contraindication, adverse event, and exemption information for the patient, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(4)(a)">(a)</span> A medical contraindication or adverse event to the administration of one or more vaccines;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(4)(b)">(b)</span> Whether the contraindication is permanent or temporary and, if temporary, the date after which the contraindication will no longer exist or needs to be reassessed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(4)(c)">(c)</span> An objection to immunization based on a bona fide religious belief and practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(5)">(5)</span> Other medical information pertaining to vaccine-preventable diseases, including serologic test results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(6)">(6)</span> Other information designated by the U.S. Centers for Disease Control and Prevention as Immunization Information System Required Core Data Elements; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#B(7)">(7)</span> Other information designated by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#C">C.</span> Correction of Inaccurate Information. A patient or a parent or a guardian of a minor patient whose immunization information is entered into ImmuNet may contact the Department to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#C(1)">(1)</span> View the information; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.04#C(2)">(2)</span> Provide information to correct any inaccuracies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.05" data-order="|10|06|03|.05|" data-ref-path="10|06|03|.05" class="h__section">.05 User Agreement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#A">A.</span> An authorized user who wishes to obtain information from ImmuNet shall enter into a user agreement with the Department for the purpose of protecting the confidentiality and security of ImmuNet information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#B">B.</span> The user agreement shall include but not be limited to the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#B(1)">(1)</span> Functions that may be performed by an authorized user of ImmuNet;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#B(2)">(2)</span> Authorized uses of ImmuNet information as set forth in Health-General Article, §18-109(c), Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#B(3)">(3)</span> Prohibitive uses of ImmuNet information as set forth in Health-General Article, §18-109(f), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#B(4)">(4)</span> Basic practices for safeguarding confidential information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#C">C.</span> Authorized users shall request the renewal of the user agreement on an annual basis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D">D.</span> Authorized User Functions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)">(1)</span> An authorized user who has signed a user agreement may obtain the following information about an individual from ImmuNet:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(a)">(a)</span> First, middle, and last name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(b)">(b)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(c)">(c)</span> Address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(d)">(d)</span> Telephone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(e)">(e)</span> In the case of a minor child, the name of the parent or guardian;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(f)">(f)</span> Immunizations given;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(g)">(g)</span> Immunization dates;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(h)">(h)</span> Contraindication, adverse event, and exemption information; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(1)(i)">(i)</span> Other medical information pertaining to vaccine-preventable diseases, including serologic test results.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(2)">(2)</span> An authorized user that is a health care provider, local health department, long-term care facility, or school-based health center that administers immunizations may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(2)(a)">(a)</span> Enter information into ImmuNet directly from medical records that are in the authorized user’s possession; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(2)(b)">(b)</span> Edit information the authorized user has entered into ImmuNet.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(3)">(3)</span> An authorized user who is a patient or a parent or guardian of a minor may view the patient’s or the minor patient’s ImmuNet information without signing a user agreement by requesting the information from the patient’s or minor’s immunization provider or the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)">(4)</span> With approval from the Department, the following authorized users may enter information into ImmuNet:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(a)">(a)</span> A child care facility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(b)">(b)</span> A health insurer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(c)">(c)</span> A health maintenance organization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(d)">(d)</span> An institution of higher learning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(e)">(e)</span> A managed care organization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(f)">(f)</span> A nonprofit health service plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.05#D(4)(g)">(g)</span> A school.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.06" data-order="|10|06|03|.06|" data-ref-path="10|06|03|.06" class="h__section">.06 Refusal and Reactivation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.06#A">A.</span> An individual or a parent or guardian of a minor child who has received an immunization may at any time prohibit information in ImmuNet from being disclosed to authorized users by providing to the Department a signed and dated Refusal to Permit Disclosure of Information form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.06#B">B.</span> An individual or a parent or guardian of a minor who has submitted a Refusal to Permit Disclosure of Information form may allow information in ImmuNet to be disclosed by submitting to the Department a signed and dated written Statement of Reactivation of Participation in ImmuNet form.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.07" data-order="|10|06|03|.07|" data-ref-path="10|06|03|.07" class="h__section">.07 Permissible Use of ImmuNet Information.</h3>
                <p>Information in ImmuNet may be used by authorized users for the following purposes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#A">A.</span> To provide coordinated immunization services, including sending reminder notices to individuals who need immunizations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#B">B.</span> To obtain an individual immunization history;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#C">C.</span> To identify geographic areas or population groups who are underimmunized;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#D">D.</span> To compile aggregate information and distribute statistical reports on the status of immunizations in geographic areas and population groups;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#E">E.</span> To assist in the management of State and local immunization programs;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#F">F.</span> To monitor the safety of vaccines;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#G">G.</span> To assess compliance with immunization requirements by monitoring admissions to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#G(1)">(1)</span> Schools;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#G(2)">(2)</span> Institutions of higher learning; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#G(3)">(3)</span> Child care facilities; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.07#H">H.</span> For any other purpose that the Secretary deems necessary to prevent the spread of communicable diseases or assess the safety or effectiveness of vaccines in accordance with Health-General Article, §18-109(c), Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.08" data-order="|10|06|03|.08|" data-ref-path="10|06|03|.08" class="h__section">.08 Regional and Other State Immunization Registries.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.08#A">A.</span> A regional registry shall submit to ImmuNet all immunization information on Maryland residents within 14 calendar days of receipt of the information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.08#B">B.</span> If the confidentiality of records of Maryland citizens is protected, the Department may enter into a collaborative agreement with other states for the purpose of sharing immunization information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.03.09" data-order="|10|06|03|.09|" data-ref-path="10|06|03|.09" class="h__section">.09 Security and Reliability Standards.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#A">A.</span> The Department shall maintain ImmuNet in accordance with system security requirements for federal information processing systems, including National Institute of Standards and Technology (NIST) 800-53 Special Publication, and prevailing agency information technology security policy standards and requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#B">B.</span> ImmuNet Security.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#B(1)">(1)</span> The Department shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#B(1)(a)">(a)</span> Maintain ImmuNet information on a server protected by a firewall; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#B(1)(b)">(b)</span> Encrypt information traveling to and from authorized users.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.03.09#B(2)">(2)</span> The Department shall maintain encryption keys in a secure location.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.04" data-order="|10|06|04|" data-ref-path="10|06|04" class="h__chapter">Chapter 04 School Health Services and Required Immunizations Before Entry into School</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.01" title=".01 School Health Services.">Regulation .01</a> amended as an emergency provision effective May 10, 1977 (4:11 Md. R. 865); emergency status extended at 4:22 Md. R. 1667 and 4:27 Md. R. 2095 (Emergency provisions are temporary and not printed in COMAR)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.01" title=".01 School Health Services.">Regulation .01</a> amended effective December 16, 1977 (4:26 Md. R. 2024) and May 18, 1979 (6:10 Md. R. 842)</p>
                  <p>Regulation .01A amended and C adopted effective February 11, 1985 (12:3 Md. R. 245)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03</a> amended effective January 2, 1984 (10:26 Md. R. 2340)</p>
                  <p>——————</p>
                  <p>Annotation: <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">COMAR 10.06.04.03</a> cited in Davis v. State, 294 Md. 370 (1982), in which the court held that "membership in a recognized religious group cannot be required as a condition of exemption from vaccination". The religious exemption was held to contravene the Establishment Clause of the First Amendment and was therefore invalid. The immunization requirement itself was found to be severable and remains in force.</p>
                  <p>——————</p>
                  <p>Chapter revised effective March 30, 1992 (19:6 Md. R. 672)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03</a> amended effective April 22, 1996 (23:8 Md. R. 605); May 19, 1997 (24:10 Md. R. 710)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.01" title=".01 School Health Services.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.10" title=".10 Responsible Agencies.">.10</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.01" title=".01 School Health Services.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.10" title=".10 Responsible Agencies.">.10</a> adopted effective November 24, 2005 (32:23 Md. R. 1826)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03</a> amended effective November 12, 2012 (39:22 Md. R. 1428)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03#E" title="">Regulation .03E</a> amended as an emergency provision effective July 1, 2006 (33:15 Md. R. 1273); amended permanently effective September 25, 2006 (33:19 Md. R. 1560)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.03#F" title="">Regulation .03F</a> adopted as an emergency provision effective March 20, 2007 (34:8 Md. R. 766); emergency provision expired</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=ged&amp;section=7-403" title="">Education Article, §7-403 </a>and Health-General Article, §18-102(a), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.04.01" data-order="|10|06|04|.01|" data-ref-path="10|06|04|.01" class="h__section">.01 School Health Services.</h3>
                <p>The local health department shall cooperate with the local school system in implementing the School Health Services regulations found in COMAR 13A.05.05.05—15.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.02" data-order="|10|06|04|.02|" data-ref-path="10|06|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(1)">(1)</span> "Health officer" means the health officer in each of the 23 counties of Maryland and the Commissioner of Health in Baltimore City, the designated representative of the health officer, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(2)">(2)</span> "Preschool program" means a program that enrolls children in an educational program below the level of kindergarten.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(3)">(3)</span> "Regulated child care program" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(3)(a)">(a)</span> A family day care provider registered pursuant to COMAR 07.04.01;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(3)(b)">(b)</span> The operator of a child care center licensed pursuant to COMAR 07.04.02; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(3)(c)">(c)</span> The operator of a child care facility issued a letter of compliance pursuant to COMAR 07.04.05.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.02#B(4)">(4)</span> "Secretary" means the Secretary of Health or the Secretary's designee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.03" data-order="|10|06|04|.03|" data-ref-path="10|06|04|.03" class="h__section">.03 Required Immunizations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A">A.</span> Except as provided in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.04" title=".04 Medical Contraindications.">.04</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.06" title=".06 Temporary Admission or Retention.">.06</a> of this chapter, a preschool or school principal or other person in charge of a preschool or school, public or private, may not knowingly admit a student to or retain a student in a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(1)">(1)</span> Preschool program unless the student's parent or guardian has furnished evidence of age-appropriate immunity against Haemophilus influenzae, type b, and pneumococcal disease;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(2)">(2)</span> Preschool program or kindergarten through the second grade of school unless the student's parent or guardian has furnished evidence of age-appropriate immunity against pertussis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)">(3)</span> Preschool program or kindergarten through the 12th grade unless the student's parent or guardian has furnished evidence of age-appropriate immunity against:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(a)">(a)</span> Tetanus;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(b)">(b)</span> Diphtheria;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(c)">(c)</span> Poliomyelitis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(d)">(d)</span> Measles (rubeola);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(e)">(e)</span> Mumps;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(f)">(f)</span> Rubella;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(g)">(g)</span> Hepatitis B;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(h)">(h)</span> Varicella;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(i)">(i)</span> Meningitis; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#A(3)(j)">(j)</span> Tetanus-diphtheria-acellular pertussis acquired through a Tetanus-diphtheria-acellular pertussis (Tdap) vaccine.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B">B.</span> Except as provided in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.04" title=".04 Medical Contraindications.">.04</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.06" title=".06 Temporary Admission or Retention.">.06</a> of this chapter, a parent or guardian shall provide evidence of age-appropriate immunity to the preschool or school authority on a form provided by the Secretary or on a printed or computer-generated form that lists the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B(1)">(1)</span> Name of the student;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B(2)">(2)</span> Date of birth;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B(3)">(3)</span> Name and address of parent or guardian;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B(4)">(4)</span> Complete history of vaccines received with month, day, and year of each vaccine dose; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#B(5)">(5)</span> Signature, title, and date of the physician, health official, school official, or regulated child care program providing the information on the form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#C">C.</span> Except as provided in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.04" title=".04 Medical Contraindications.">.04</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.04.06" title=".06 Temporary Admission or Retention.">.06</a> of this chapter and <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#A(3)" title="">§A(3) of this regulation</a>, a student shall obtain immunizations in accordance with the schedule of immunizations recommended by the Medical and Chirurgical Faculty of Maryland and the Secretary, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#D" title="">§D of this regulation</a> and as required to be implemented in §§E and F of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D">D.</span> Schedule of Immunizations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(1)">(1)</span> Student in Preschool. In order for the immunization status of a student enrolled in a preschool to be complete, the student's parent or guardian shall provide proof of the following doses of immunizations:</p>
                <div class="table_wrap">
                  <table class="layout-table">
                    <thead>
                      <tr>
                        <th>Age of Student</th>
                        <th>Diphtheria, <br/>Tetanus,<br/>Pertussis</th>
                        <th>Poliomyelitis</th>
                        <th>Haemophilus influenzae, type B</th>
                        <th>Measles, <br/>Mumps, <br/>Rubella</th>
                        <th>Hepatitis B</th>
                        <th>Varicella</th>
                        <th>Pneumococcal</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td>Less than 2 months</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                      </tr>
                      <tr>
                        <td>2—3 months</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                      </tr>
                      <tr>
                        <td>4—5 months</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                      </tr>
                      <tr>
                        <td>6—11 months</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                      </tr>
                      <tr>
                        <td>12—14 months</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">At least 1 dose after 12 months old</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                      </tr>
                      <tr>
                        <td>15—23 months</td>
                        <td data-text-align="center" data-vertical-align="middle">4</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">At least 1 dose after 12 months old</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                      </tr>
                      <tr>
                        <td>24—59 months</td>
                        <td data-text-align="center" data-vertical-align="middle">4</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">At least 1 dose after 12 months old</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                      </tr>
                      <tr>
                        <td>60—71 months</td>
                        <td data-text-align="center" data-vertical-align="middle">4</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                        <td data-text-align="center" data-vertical-align="middle">2</td>
                        <td data-text-align="center" data-vertical-align="middle">3</td>
                        <td data-text-align="center" data-vertical-align="middle">1</td>
                        <td data-text-align="center" data-vertical-align="middle">0</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)">(2)</span> Student in Kindergarten Through 12th Grade.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(a)">(a)</span> In order for the immunization status of a student enrolled in kindergarten through 12th grade to be complete, the student's parent or guardian shall provide proof of the immunizations or immunity as outlined in §D(2)(b)—(l) of this regulation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(b)">(b)</span> Diphtheria.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(b)(i)">(i)</span> Four doses of diphtheria immunization vaccine are required for a student younger than 7 years old; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(b)(ii)">(ii)</span> Three doses of diphtheria immunization vaccine are required for a student 7 years old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(c)">(c)</span> Tetanus.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(c)(i)">(i)</span> Four doses of tetanus immunization vaccine are required for a student younger than 7 years old; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(c)(ii)">(ii)</span> Three doses of tetanus immunization vaccine are required for a student 7 years old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(d)">(d)</span> Pertussis. Four doses of pertussis immunization vaccine are required for a student younger than 7 years old.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(e)">(e)</span> Poliomyelitis (Oral or Injectable).</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(e)(i)">(i)</span> Three doses of poliomyelitis immunization vaccine are required for a student younger than 18 years old; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(e)(ii)">(ii)</span> Proof of immunity from poliomyelitis by blood test is required for a student younger than 18 years old.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(f)">(f)</span> Rubella.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(f)(i)">(i)</span> Two doses of live rubella virus vaccine are required when the student is 1 year old or older; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(f)(ii)">(ii)</span> Proof of immunity from rubella by blood test is required when the student is 1 year old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(g)">(g)</span> Measles (rubeola).</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(g)(i)">(i)</span> Two doses of live measles (rubeola) virus vaccine are required when the student is 1 year old or older; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(g)(ii)">(ii)</span> Proof of immunity from rubeola by blood test is required when the student is 1 year old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(h)">(h)</span> Mumps.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(h)(i)">(i)</span> Two doses of live mumps virus vaccine are required when the student is 1 year old or older; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(h)(ii)">(ii)</span> Proof of immunity from mumps by blood test is required when the student is 1 year old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(i)">(i)</span> Hepatitis B.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(i)(i)">(i)</span> Three doses of hepatitis B vaccine are required; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(i)(ii)">(ii)</span> Proof of immunity from hepatitis B by blood test is required.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(j)">(j)</span> Varicella.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(j)(i)">(i)</span> All doses of varicella vaccine shall be given when the student is 1 year old or older.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(j)(ii)">(ii)</span> Per the schedule of implementation in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#E(1)" title="">§E(1) of this regulation</a> and except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#D(2)(j)(iii)" title="">§D(2)(j)(iii) of this regulation</a>, one dose of live varicella vaccine is required for a student younger than 13 years old, or two doses of live varicella vaccine are required for a student 13 years old or older, if the student does not have proof of vaccination against varicella at an age younger than 13 years old.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(j)(iii)">(iii)</span> Proof of immunity from varicella by blood test or by medical diagnosis indicated by month and year of diagnosis may be provided instead of meeting the requirements of §D(2)(j)(ii) or (iv) of this regulation.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(j)(iv)">(iv)</span> Per the schedule of implementation in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#E(2)" title="">§E(2) of this regulation</a> and except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#D(2)(j)(iii)" title="">§D(2)(j)(iii) of this regulation</a>, two doses of live varicella vaccine are required.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(k)">(k)</span> Meningococcal. One dose of meningococcal vaccine is required per the schedule of implementation in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(2)(l)">(l)</span> Tetanus-diphtheria-acellular pertussis (Tdap). One dose of Tetanus-diphtheria-acellular pertussis (Tdap) immunization vaccine is required per the schedule of implementation in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#D(3)">(3)</span> Record Review for Student in Preschool Through 12th Grade. A preschool or school, public or private, may count as valid, vaccine doses administered less than or equal to 4 days before the minimum interval or age.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E">E.</span> Schedule of Implementation: Varicella Effective Immunization Dates for a Student in Kindergarten Through 12th Grade.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(1)">(1)</span> As set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#E(2)" title="">§E(2) of this regulation</a>, by the date listed in Column 1, the parent or guardian of a student entering the grade listed in Column 2 shall provide proof to the school that the student:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(1)(a)">(a)</span> Has received age appropriate vaccination with varicella vaccine; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(1)(b)">(b)</span> Is immune to varicella by providing the results of a blood test or a medical diagnosis indicated by month and year of diagnosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(2)">(2)</span> One-Dose Requirement Immunization Dates for a Student in Kindergarten Through 12th Grade.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Date</th>
                        <th>Grade</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">September 2011, 2012, 2013</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2014</td>
                        <td data-vertical-align="middle">1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2015</td>
                        <td data-vertical-align="middle">2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2016</td>
                        <td data-vertical-align="middle">3, 4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2017</td>
                        <td data-vertical-align="middle">4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2018</td>
                        <td data-vertical-align="middle">5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2019</td>
                        <td data-vertical-align="middle">6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2020</td>
                        <td data-vertical-align="middle">7, 8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2021</td>
                        <td data-vertical-align="middle">8, 9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2022</td>
                        <td data-vertical-align="middle">9, 10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2023</td>
                        <td data-vertical-align="middle">10, 11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2024</td>
                        <td data-vertical-align="middle">11, 12</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2025</td>
                        <td data-vertical-align="middle">12</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(3)">(3)</span> As set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#E(4)" title="">§E(4) of this regulation</a>, by the date listed in Column 1, the parent or guardian of a student entering the grade listed in Column 2 shall provide proof to the kindergarten or school that the student:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(3)(a)">(a)</span> Has received two doses of varicella vaccine; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(3)(b)">(b)</span> Is immune to varicella by providing the results of a blood test or a medical diagnosis indicated by month and year of diagnosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#E(4)">(4)</span> Two-Dose Requirement Immunization Dates for a Student in Kindergarten Through 12th Grade.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Date</th>
                        <th>Grade</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">September 2014</td>
                        <td data-vertical-align="middle">K</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2015</td>
                        <td data-vertical-align="middle">K, 1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2016</td>
                        <td data-vertical-align="middle">K, 1, 2</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2017</td>
                        <td data-vertical-align="middle">K, 1, 2, 3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2018</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2019</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2020</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2021</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2022</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2023</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8, 9</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2024</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2025</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2026</td>
                        <td data-vertical-align="middle">K, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#F">F.</span> Schedule of Implementation: Meningococcal and Tetanus-diphtheria-acellular pertussis (Tdap) Effective Immunization Dates for a Student in Preschool Through 12th Grade.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#F(1)">(1)</span> As set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03#F(2)" title="">§F(2) of this regulation</a>, by the date listed in Column 1, the parent or guardian of a student entering the grade listed in Column 2 shall provide proof to the preschool or school that the student has received one dose of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#F(1)(a)">(a)</span> Meningococcal immunization vaccine; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#F(1)(b)">(b)</span> Tetanus-diphtheria-acellular pertussis (Tdap) immunization vaccine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.03#F(2)">(2)</span> Immunization Dates for a Student in 7th Through 12th Grade.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Date</th>
                        <th>Grade</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">September 2014</td>
                        <td data-vertical-align="middle">7</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2015</td>
                        <td data-vertical-align="middle">7, 8</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2016</td>
                        <td data-vertical-align="middle">7, 8, 9</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2017</td>
                        <td data-vertical-align="middle">7, 8, 9, 10</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2018</td>
                        <td data-vertical-align="middle">7, 8, 9, 10, 11</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">September 2019</td>
                        <td data-vertical-align="middle">7, 8, 9, 10, 11, 12</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.04" data-order="|10|06|04|.04|" data-ref-path="10|06|04|.04" class="h__section">.04 Medical Contraindications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#A">A.</span> The requirements of <a class="internal-link " href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03 of this chapter</a> do not apply to a student who presents a licensed physician's or health officer's written statement that the student's immunization against a disease in <a class="internal-link " href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03 of this chapter</a> is medically contraindicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#B">B.</span> The physician or health officer shall indicate in the statement presented under <a class="internal-link " href="/us/md/exec/comar/10.06.04.04#A" title="">§A of this regulation</a> whether the contraindication is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#B(1)">(1)</span> Permanent; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#B(2)">(2)</span> Temporary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#C">C.</span> If the contraindication is temporary:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#C(1)">(1)</span> The physician or health officer shall provide in the statement presented under <a class="internal-link " href="/us/md/exec/comar/10.06.04.04#A" title="">§A of this regulation</a> an estimate of when the immunization may be obtained by the student; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#C(2)">(2)</span> The student's parent or guardian shall furnish to the preschool or school evidence of the completion of the immunization in accordance with the estimate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#D">D.</span> A preschool or school, public or private, shall maintain a current list of all students enrolled who have an exemption to immunizations on medical grounds.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.04#E">E.</span> Annually, by November 15, a preschool or school, public or private, shall report to the Secretary of Health the number of students with a medical exemption enrolled in all grades.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.05" data-order="|10|06|04|.05|" data-ref-path="10|06|04|.05" class="h__section">.05 Religious Exemption.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.05#A">A.</span> Using the form provided by the Maryland Department of Health, a student whose parent or guardian objects to immunization on the ground that the immunization conflicts with the parent's or guardian's bona fide religious beliefs and practices is exempt from the requirement to present a physician's certificate of immunization in order that the student be admitted to school.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.05#B">B.</span> The exemption allowed under <a class="internal-link " href="/us/md/exec/comar/10.06.04.05#A" title="">§A of this regulation</a> does not apply when the Secretary declares an emergency or epidemic of disease.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.05#C">C.</span> A preschool or school, public or private, shall maintain a current list of all students enrolled who have an exemption to immunizations on religious grounds.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.05#D">D.</span> Annually, by November 15th, a preschool or school, public or private, shall report to the Secretary of Health the number of students with a religious exemption enrolled in all grades.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.06" data-order="|10|06|04|.06|" data-ref-path="10|06|04|.06" class="h__section">.06 Temporary Admission or Retention.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#A">A.</span> Subject to the provisions of <a class="internal-link " href="/us/md/exec/comar/10.06.04.06#B" title="">§B of this regulation</a>, a preschool or school, public or private, shall temporarily admit a student to or retain a student in a preschool or school if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#A(1)">(1)</span> The student is homeless; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#A(2)">(2)</span> The student's parent or guardian is unable to provide proof of immunization pursuant to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.06.04.03" title=".03 Required Immunizations.">Regulation .03 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#B">B.</span> In order for a student to be temporarily admitted to or retained in a preschool or school, the student's parent or guardian shall present evidence of the student's appointment with a health care provider or local health department to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#B(1)">(1)</span> Receive a required immunization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#B(2)">(2)</span> Reconstruct a lost record; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#B(3)">(3)</span> Acquire evidence of age-appropriate immunity on a form provided by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#C">C.</span> The date of the appointment pursuant to <a class="internal-link " href="/us/md/exec/comar/10.06.04.06#B" title="">§B of this regulation</a> may not be later than 20 calendar days following the date the student was temporarily admitted or retained.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.06#D">D.</span> A preschool or school, public or private, shall exclude from school a student who has been temporarily admitted or retained on the next school day following the appointment date if the student's parent or guardian fails to provide evidence of required immunizations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.07" data-order="|10|06|04|.07|" data-ref-path="10|06|04|.07" class="h__section">.07 Vaccine Provision.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.07#A">A.</span> A student may have an immunization administered by the student's personal physician.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.07#B">B.</span> If a parent or guardian cannot obtain the service of a private physician, the parent or guardian of the student may take the student to the local health department for the immunizations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.04.07#C">C.</span> A local health department shall provide the immunization referenced in <a class="internal-link " href="/us/md/exec/comar/10.06.04.07#B" title="">§B of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.08" data-order="|10|06|04|.08|" data-ref-path="10|06|04|.08" class="h__section">.08 Record Review.</h3>
                <p>A preschool or school, public or private, shall make immunization records of students available for review by a health officer as needed to assure compliance with regulations or to ascertain the immunization status of students.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.09" data-order="|10|06|04|.09|" data-ref-path="10|06|04|.09" class="h__section">.09 Report on New Students.</h3>
                <p>Annually, by November 15, on a form provided by the Department, a preschool or school, public or private, shall provide the health officer of the jurisdiction where the school is located with an immunization report of students in preschool through 12th grade who are new to the school.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.04.10" data-order="|10|06|04|.10|" data-ref-path="10|06|04|.10" class="h__section">.10 Responsible Agencies.</h3>
                <p>The local superintendents of schools and the local health officers shall be responsible for carrying out the provisions of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.05" data-order="|10|06|05|" data-ref-path="10|06|05" class="h__chapter">Chapter 05 Meningococcal Vaccination Requirements for Students in Institutions of Higher Education</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 12, 2001 (28:22 Md. R. 1937)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §18-102(b), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.05.01" data-order="|10|06|05|.01|" data-ref-path="10|06|05|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to meningococcal vaccination of individuals enrolled in institutions of higher education who are living in on-campus student housing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.02" data-order="|10|06|05|.02|" data-ref-path="10|06|05|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#B(1)">(1)</span> "Enrolled" means having registered for a credit or noncredit course.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#B(2)">(2)</span> "Institution of higher education" means a school of post-secondary education that generally limits enrollment to graduates of secondary schools and awards degrees at the associate, baccalaureate, or graduate level.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#B(3)">(3)</span> "Meningococcal vaccination" means receipt of the vaccine protecting against at least the four serogroups of A, C, Y, and W-135 of meningococcal disease within the preceding 5 years before the individual moves into on-campus student housing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.02#B(4)">(4)</span> "On-campus student housing" means housing provided to individuals, regardless of the fee, that is owned, rented, or contracted for and operated by an institution of higher education, or through written agreement, with an agent of the institution of higher education.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.03" data-order="|10|06|05|.03|" data-ref-path="10|06|05|.03" class="h__section">.03 Required Meningococcal Vaccination.</h3>
                <p>Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.05.05" title=".05 Exemption from Meningococcal Vaccination Requirement.">Regulation .05 of this chapter</a>, an individual enrolled in an institution of higher education living in on-campus student housing shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.03#A">A.</span> Obtain a meningococcal vaccination; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.03#B">B.</span> Submit written documentation to the institution of higher education from a health care professional or clinic of receipt of a meningococcal vaccination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.04" data-order="|10|06|05|.04|" data-ref-path="10|06|05|.04" class="h__section">.04 Notification of Required Meningococcal Vaccination.</h3>
                <p>An institution of higher education shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#A">A.</span> Inform an individual or the parent or guardian of an individual younger than 18 years old of the requirement for meningococcal vaccination at the time the individual:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#A(1)">(1)</span> Is accepted for admission to an institution of higher education; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#A(2)">(2)</span> Registers for classes, if the individual is not required to apply for admission before registering for courses;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B">B.</span> Include notice of the requirement for meningococcal vaccination in:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B(1)">(1)</span> Admission acceptance information;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B(2)">(2)</span> Student health-related information and materials;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B(3)">(3)</span> Resident life information and materials;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B(4)">(4)</span> The student handbook; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#B(5)">(5)</span> The college catalog; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#C">C.</span> Provide detailed information to an individual who resides or may reside in on-campus student housing or the parent or guardian of an individual younger than 18 years old who resides or may reside in on-campus student housing concerning:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#C(1)">(1)</span> The risks associated with meningococcal disease; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.04#C(2)">(2)</span> The availability and effectiveness of meningococcal vaccine.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.05" data-order="|10|06|05|.05|" data-ref-path="10|06|05|.05" class="h__section">.05 Exemption from Meningococcal Vaccination Requirement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#A">A.</span> An individual 18 years old or older is exempt from the meningococcal vaccination requirement set forth at <a class="internal-link " href="/us/md/exec/comar/10.06.05.03" title=".03 Required Meningococcal Vaccination.">Regulation .03 of this chapter</a> if the individual presents to the institution of higher education a signed written waiver as set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.05.06#A" title="">Regulation .06A of this chapter</a> stating that the individual has:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#A(1)">(1)</span> Received and reviewed the information specified in <a class="internal-link " href="/us/md/exec/comar/10.06.05.04#C" title="">Regulation .04C of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#A(2)">(2)</span> Chosen not to obtain the meningococcal vaccination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#B">B.</span> An individual younger than 18 years old is exempt from the meningococcal vaccination requirement set forth at <a class="internal-link " href="/us/md/exec/comar/10.06.05.03" title=".03 Required Meningococcal Vaccination.">Regulation .03 of this chapter</a> if a signed written waiver as set forth in <a class="internal-link " href="/us/md/exec/comar/10.06.05.06#B" title="">Regulation .06B of this chapter</a> is presented to the institution of higher education on behalf of the individual stating that a parent or guardian of the individual has:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#B(1)">(1)</span> Received and reviewed the information specified in <a class="internal-link " href="/us/md/exec/comar/10.06.05.04#C" title="">Regulation .04C of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.05#B(2)">(2)</span> Chosen not to have the individual obtain the meningococcal vaccination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.06" data-order="|10|06|05|.06|" data-ref-path="10|06|05|.06" class="h__section">.06 Waiver Form.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A">A.</span> A waiver form for an individual 18 years old or older shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(1)">(1)</span> State that the individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(1)(a)">(a)</span> Is 18 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(1)(b)">(b)</span> Has received and reviewed the information provided by the institution of higher education on the risk of meningococcal disease and the availability and effectiveness of meningococcal vaccine; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(1)(c)">(c)</span> Chooses to waive the receipt of meningococcal vaccine; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(2)">(2)</span> Provide spaces for the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(2)(a)">(a)</span> Printed name of the individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(2)(b)">(b)</span> Signature of the individual; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#A(2)(c)">(c)</span> Date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B">B.</span> A waiver form for an individual younger than 18 years old shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(1)">(1)</span> State that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(1)(a)">(a)</span> The individual is younger than 18 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(1)(b)">(b)</span> The parent or guardian of the individual has received and reviewed the information provided by the institution of higher education on the risk of meningococcal disease and the availability and effectiveness of meningococcal vaccine; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(1)(c)">(c)</span> The parent or guardian of the individual chooses to waive the receipt of meningococcal vaccine for the individual; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(2)">(2)</span> Provide spaces for the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(2)(a)">(a)</span> Printed name of the individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(2)(b)">(b)</span> Printed name of the parent or guardian;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(2)(c)">(c)</span> Signature of the parent or guardian; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.05.06#B(2)(d)">(d)</span> Date.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.05.07" data-order="|10|06|05|.07|" data-ref-path="10|06|05|.07" class="h__section">.07 Payment for Meningococcal Vaccination.</h3>
                <p>Nothing in this chapter shall be construed to require an institution of higher education or a local public health agency to provide or pay for a meningococcal vaccination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.06" data-order="|10|06|06|" data-ref-path="10|06|06" class="h__chapter">Chapter 06 Communicable Disease Prevention — Handling, Treatment, and Disposal of Special Medical Waste</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.08" title=".08 Enforcement.">.08</a> adopted as an emergency provision effective September 30, 1988 (15:22 Md. R. 2547); emergency status expired March 29, 1989; adopted permanently effective May 1, 1989 (16:8 Md. R. 909)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.02#B" title="">Regulation .02B</a> amended effective December 20, 1993 (20:25 Md. R. 1947)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.04#B" title="">Regulation .04B</a> amended effective December 20, 1993 (20:25 Md. R. 1947)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.06#B" title="">Regulation .06B</a> amended effective December 20, 1993 (20:25 Md. R. 1947)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.07#C" title="">Regulation .07C</a> amended effective December 20, 1993 (20:25 Md. R. 1947)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.07" title=".07 Disposal of Special Medical Waste.">.07</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.07" title=".07 Disposal of Special Medical Waste.">.07</a> adopted effective September 1, 2004 (31:16 Md. R. 1254)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.02#B" title="">Regulation .02B</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.04" title=".04 Treatment of Special Medical Waste, Excluding Sharps, Before Disposal.">Regulation .04</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.06#A" title="">Regulation .06A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.07" title=".07 Disposal of Special Medical Waste.">Regulation .07</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §18-102, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.06.01" data-order="|10|06|06|.01|" data-ref-path="10|06|06|.01" class="h__section">.01 Scope and Purpose.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A">A.</span> Scope.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(1)">(1)</span> Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.03" title=".03 Handling of Special Medical Waste.">.03</a> apply to a person who generates and handles special medical waste or sharps.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(2)">(2)</span> Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.06.07" title=".07 Disposal of Special Medical Waste.">.07</a> apply to a person who treats and disposes of special medical waste.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(3)">(3)</span> This chapter does not apply to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(3)(a)">(a)</span> Waste generated from veterinary practices that is governed by <a class="internal-link no-wrap" href="/us/md/exec/comar/15.14.03.02" title=".02 Sanitation Practices.">COMAR 15.14.03.02</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(3)(b)">(b)</span> Radioactive medical waste that is governed by <a class="internal-link no-wrap" href="/us/md/exec/comar/26.12.01.01" title=".01 Incorporation by Reference.">COMAR 26.12.01.01</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(3)(c)">(c)</span> Remains of a dead human; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#A(3)(d)">(d)</span> Fetuses and placentas that are released to a funeral director or a parent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.01#B">B.</span> Purpose. The purpose of this chapter is to minimize the possibility of disease transmission by establishing requirements for the handling, treatment, and disposal of special medical waste.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.02" data-order="|10|06|06|.02|" data-ref-path="10|06|06|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(1)">(1)</span> "Anatomical material" means human or animal body parts, including tissues and organs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(2)">(2)</span> "Autoclaving" means a process by which an article is subjected to steam under pressure for documented periods of time, temperature, and pressure that render the article incapable of transmitting disease to humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(3)">(3)</span> "Blood" means human blood, human blood components, and products made from human blood.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)">(4)</span> Bloodborne Pathogens.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(a)">(a)</span> "Bloodborne pathogens" means pathogenic microorganisms that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(a)(i)">(i)</span> Are present in human blood; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(a)(ii)">(ii)</span> Can cause disease in humans.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(b)">(b)</span> "Bloodborne pathogens" includes, but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(b)(i)">(i)</span> Human immunodeficiency virus;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(b)(ii)">(ii)</span> Hepatitis B virus; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(4)(b)(iii)">(iii)</span> Hepatitis C virus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(5)">(5)</span> "Chemical disinfection" means the application of a chemical agent to an article, so that the article is rendered incapable of transmitting disease to humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(6)">(6)</span> "Contaminated" means the presence or the reasonably anticipated presence of blood or other potentially infectious materials on an item or surface.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(7)">(7)</span> "Cremation" means the incineration of human or animal remains.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(8)">(8)</span> "Decontamination" means the use of physical or chemical means to remove, inactivate, or destroy bloodborne pathogens on an article to render the article incapable of transmitting disease to humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(9)">(9)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(10)">(10)</span> "Disinfection" means a method that inactivates:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(10)(a)">(a)</span> Vegetative bacteria, fungi, lipophilic/hydrophilic viruses, parasites, and mycobacteria at a 6 log reduction or greater; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(10)(b)">(b)</span> Bacillus stearothermophilus spores and Bacillus subtilis spores at a 4 log reduction or greater.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(11)">(11)</span> "Encapsulation" means a process by which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(11)(a)">(a)</span> An article is sealed in a material that renders the article no longer recognizable or capable of transmitting disease to humans; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(11)(b)">(b)</span> The sealed material:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(11)(b)(i)">(i)</span> Is decontaminated or disinfected during the encapsulation process; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(11)(b)(ii)">(ii)</span> Remains sealed under physical stress.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(12)">(12)</span> "Incineration" means a process during which an article is burned:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(12)(a)">(a)</span> In an incinerator that meets the requirements of the Department of the Environment as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/26.11.08" title="Chapter 08 Control of Incinerators">COMAR 26.11.08</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(12)(b)">(b)</span> To carbonized or mineralized ash that is capable of disposal as solid waste; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(12)(c)">(c)</span> So the article is rendered incapable of transmitting disease to humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(13)">(13)</span> "Infectious agent" means an organism, including viral, rickettsial, bacterial, fungal, protozoal, or helminthic, that is capable of producing infection or infectious disease in humans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(14)">(14)</span> "Interment" means burial in a location, other than a landfill, that is approved for that purpose under applicable law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(15)">(15)</span> "Mechanical destruction" means a physical process that renders an article no longer recognizable as the original article.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(16)">(16)</span> "Microbiological laboratory waste" means waste from a microbiological laboratory that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(16)(a)">(a)</span> Contains an infectious agent; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(16)(b)">(b)</span> Includes cultures and stocks of infectious agents and associated biologicals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(17)">(17)</span> "Occupational exposure" means skin, eye, mucous membrane, or parenteral contact with blood or other potentially infectious materials, that results from the performance of an employee's duties.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)">(18)</span> "Other potentially infectious material" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)">(a)</span> The following human body fluids:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(i)">(i)</span> Amniotic fluid;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(ii)">(ii)</span> A body fluid that is visibly contaminated with blood;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(iii)">(iii)</span> A body fluid that cannot be readily identified;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(iv)">(iv)</span> Cerebrospinal fluid;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(v)">(v)</span> Pericardial fluid;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(vi)">(vi)</span> Peritoneal fluid;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(vii)">(vii)</span> Pleural fluid;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(viii)">(viii)</span> Saliva only when dental procedures are performed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(ix)">(ix)</span> Semen;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(x)">(x)</span> Synovial fluid; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(a)(xi)">(xi)</span> Vaginal secretions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(b)">(b)</span> A tissue or organ from a living or dead human, not including intact skin, that has not been preserved by a chemical additive or preservative;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(c)">(c)</span> The following human immunodeficiency virus, hepatitis B virus, or hepatitis C virus related items:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(c)(i)">(i)</span> HIV containing cell, tissue, or organ cultures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(c)(ii)">(ii)</span> HIV, Hepatitis B, or Hepatitis C containing media or other solutions; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(c)(iii)">(iii)</span> Blood, organs, or other tissues; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(18)(d)">(d)</span> Microbiological laboratory waste.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(19)">(19)</span> "Person" means an individual, receiver, trustee, guardian, personal representative, fiduciary, or representative of any kind and any partnership, firm, association, corporation, or other entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(20)">(20)</span> "Sanitary sewer" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(20)(a)">(a)</span> A liquid waste piping network leading to a sewerage system permitted under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=9-204" title="">Environment Article, §9-204, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(20)(b)">(b)</span> An on-site sewerage system permitted under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=9-204" title="">Environment Article, §9-204, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)">(21)</span> "Sharps" means an object contaminated by blood or other potentially infectious material that can cut or penetrate the skin, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(a)">(a)</span> A broken capillary tube;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(b)">(b)</span> Broken glass;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(c)">(c)</span> An exposed end of dental wire;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(d)">(d)</span> A needle;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(e)">(e)</span> A surgical instrument; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(21)(f)">(f)</span> A syringe with an attached sharp.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)">(22)</span> "Special medical waste" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(a)">(a)</span> Liquid or semiliquid blood or another potentially infectious material;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(b)">(b)</span> A contaminated article that releases liquid or semiliquid blood or another potentially infectious material if compressed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(c)">(c)</span> An article that contains dried blood or another potentially infectious material and is capable of releasing the blood or material during handling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(d)">(d)</span> Pathological and microbiological waste containing blood or another potentially infectious material;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(e)">(e)</span> Contaminated sharps; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.02#B(22)(f)">(f)</span> Anatomical material.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.03" data-order="|10|06|06|.03|" data-ref-path="10|06|06|.03" class="h__section">.03 Handling of Special Medical Waste.</h3>
                <p>A person shall handle special medical waste in accordance with the requirements of:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.03#A">A.</span> 29 CFR §1910.1030(d)(4)(iii)(A) and (B), which is incorporated by reference at <a class="internal-link no-wrap" href="/us/md/exec/comar/09.12.31" title="Chapter 31 Maryland Occupational Safety and Health Regulations .01—.09">COMAR 09.12.31</a>; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.03#B">B.</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.12.05" title=".05 Pretreatment Requirements.">COMAR 26.13.12.05</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/26.13.13" title="Chapter 13 Standards Applicable to Transporters of Special Medical Waste">26.13.13</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.04" data-order="|10|06|06|.04|" data-ref-path="10|06|06|.04" class="h__section">.04 Treatment of Special Medical Waste, Excluding Sharps, Before Disposal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.06.04#B" title="">§B of this regulation</a>, a person shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(1)">(1)</span> Treat special medical waste, excluding sharps, before disposal; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)">(2)</span> Use one of the following treatment methods:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(a)">(a)</span> Autoclaving;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(b)">(b)</span> Chemical disinfection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(c)">(c)</span> Cremation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(d)">(d)</span> Disinfection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(e)">(e)</span> Mechanical destruction after decontamination;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(f)">(f)</span> Incineration; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#A(2)(g)">(g)</span> An alternative method that meets the criteria of <a class="internal-link " href="/us/md/exec/comar/10.06.06.06" title=".06 Alternative Treatment Systems.">Regulation .06 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.04#B">B.</span> A person may discharge certain special medical waste directly into a sewerage system, without treatment, in accordance with Regulation.07B of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.05" data-order="|10|06|06|.05|" data-ref-path="10|06|06|.05" class="h__section">.05 Treatment of Sharps Before Disposal.</h3>
                <p>A person shall treat sharps:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#A">A.</span> Before disposal; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#B">B.</span> By one of the following methods:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#B(1)">(1)</span> Encapsulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#B(2)">(2)</span> Incineration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#B(3)">(3)</span> Mechanical destruction after decontamination; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.05#B(4)">(4)</span> An alternative method that meets the criteria of <a class="internal-link " href="/us/md/exec/comar/10.06.06.06" title=".06 Alternative Treatment Systems.">Regulation .06 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.06" data-order="|10|06|06|.06|" data-ref-path="10|06|06|.06" class="h__section">.06 Alternative Treatment Systems.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.06.06.06#B" title="">§B of this regulation</a>, a person may not use a method for treatment of special medical waste other than those set forth at Regulations .04A(2) and .05B of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B">B.</span> Criteria for Alternative Treatment System. A person may use a method for treatment of special medical waste that complies with the following standards for treatment and microbial test procedures:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(1)">(1)</span> The method inactivates vegetative bacteria, fungi, parasites, lipophilic or hydrophilic viruses, and mycobacteria at a 6 log reduction or greater;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(2)">(2)</span> The method inactivates bacterial spores at a 4 log reduction or greater; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)">(3)</span> The tests have been performed on a representative from each of the following microbial groups:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(a)">(a)</span> Staphylococcus aureus (ATCC 6538) or Pseudomonas aeruginosa (ATCC 15422);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(b)">(b)</span> Candida albicans (ATCC 18804) or Penicillium chrysogenum (ATCC 24791);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(c)">(c)</span> Polio 2 or Polio 3 or MS-2 Bacteriophage, (ATCC 15597-B1);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(d)">(d)</span> Cryptosporidium spp. oocysts or Giardia spp. cysts;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(e)">(e)</span> Mycobacterium terrae, Mycobacterium phlei, or Mycobacterium bovis (BCG) (ATCC 35743); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#B(3)(f)">(f)</span> Bacillus stearothermophilus (ATCC 7953) or Bacillus subtilis (ATCC 19659).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#C">C.</span> A person may not use a method for treating of special medical waste that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#C(1)">(1)</span> Creates a threat to health or safety; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.06#C(2)">(2)</span> Violates applicable federal and State environmental laws or regulations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.07" data-order="|10|06|06|.07|" data-ref-path="10|06|06|.07" class="h__section">.07 Disposal of Special Medical Waste.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#A">A.</span> Subject to §§B and C of this regulation, a person shall dispose of special medical waste after treatment by one of the following methods:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#A(1)">(1)</span> Interment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#A(2)">(2)</span> Depositing in a facility approved to accept the type of solid waste being disposed in accordance with <a class="internal-link " href="/us/md/exec/comar/10.06.06.07#C" title="">§C of this regulation</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#A(3)">(3)</span> Incineration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#B">B.</span> A person may discharge a special medical waste that is liquid, semiliquid, or anatomical material that has been mechanically destroyed into a sewerage system, if the discharge is allowed under:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#B(1)">(1)</span> Local ordinance or regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#B(2)">(2)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gen/gen.pdf" title="">Environment Article, Title 9, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#C">C.</span> A person shall dispose of special medical waste in accordance with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#C(1)">(1)</span> State laws and regulations pertaining to solid waste disposal including <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gen/gen.pdf" title="">Environment Article, Title 9, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.07#C(2)">(2)</span> Local ordinances and regulations to the extent that the local requirements are not preempted by or in conflict with State law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.06.08" data-order="|10|06|06|.08|" data-ref-path="10|06|06|.08" class="h__section">.08 Enforcement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.08#A">A.</span> The Secretary may enter the property of any person who generates, handles, treats, or disposes of special medical waste to investigate a complaint the Secretary receives regarding the handling, treatment, or disposal of special medical waste.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.08#B">B.</span> Criminal Penalties.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.08#B(1)">(1)</span> A person who violates these regulations is guilty of a misdemeanor, and on conviction is subject to a fine not exceeding $500.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.06.08#B(2)">(2)</span> Each day that a violation exists shall constitute a separate offense.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.06.08#C">C.</span> In addition to any penalty under §B, if a person violates these regulations, the Secretary may suspend or revoke any license, permit, or certificate issued to the person under the Health-General Article, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.06.07" data-order="|10|06|07|" data-ref-path="10|06|07" class="h__chapter">Chapter 07 Sexually Transmitted Infections — Expedited Partner Therapy for Chlamydia, Gonorrhea, and Trichomoniasis</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 28, 2016 (43:6 Md. R. 406)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.07.01#A" title="">Regulation .01A</a> amended effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.07.02#B" title="">Regulation .02B</a> amended effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.07.04-1" title=".04-1 Pharmacists Authorized to Dispense EPT.">Regulation .04-1</a> adopted effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.07.05#A" title="">Regulation .05A</a>, B amended effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.07.06#C" title="">Regulation .06C</a> amended effective March 26, 2018 (45:6 Md. R. 318)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b), 18-102, 18-201, 18-202, and 18-214.1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.06.07.01" data-order="|10|06|07|.01|" data-ref-path="10|06|07|.01" class="h__section">.01 Purpose and Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.01#A">A.</span> The purpose of expedited partner therapy in Maryland is to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.01#A(1)">(1)</span> Provide antibiotic therapy to any partner of a patient diagnosed with chlamydia, gonorrhea, or trichomoniasis without a personal physical assessment of the partner, and without having a previous provider-patient relationship with the partner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.01#A(2)">(2)</span> Contain and stop the further spread of chlamydia, gonorrhea, and trichomoniasis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.01#A(3)">(3)</span> Reduce the likelihood of reinfection in the diagnosed patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.01#B">B.</span> This chapter applies to the provision of expedited partner therapy, as described in <a class="internal-link " href="/us/md/exec/comar/10.06.07.01#A" title="">§A of this regulation</a>, in public and private health care settings.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.02" data-order="|10|06|07|.02|" data-ref-path="10|06|07|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(1)">(1)</span> “Antibiotic therapy” means the oral antibiotic treatment regimens:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(1)(a)">(a)</span> Currently recommended by the Centers for Disease Control and Prevention for the treatment of chlamydia and gonorrhea through expedited partner therapy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(1)(b)">(b)</span> For the treatment of trichomoniasis through expedited partner therapy:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(1)(b)(i)">(i)</span> In accordance with <a class="internal-link " href="/us/md/exec/comar/10.06.07.05#A" title="">Regulation .05A of this chapter</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(1)(b)(ii)">(ii)</span> As authorized by Health-General Article, §18-214.1, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(2)">(2)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(3)">(3)</span> “Expedited partner therapy (EPT)” means the prescribing or dispensing of antibiotic therapy to any partner of a patient diagnosed with chlamydia, gonorrhea, or trichomoniasis by certain health care providers without making a personal physical assessment of the partner, and without having a previous provider-patient relationship with the partner, in order to contain and stop the further spread of the infection and reduce the likelihood of reinfection in the diagnosed patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(4)">(4)</span> “Health officer” means the health officer in each of the 23 counties and the Commissioner of Health in Baltimore City, or the duly designated representative of the health officer, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.02#B(5)">(5)</span> “Partner” means an individual with whom one has, or has had, oral, anal or vaginal sexual contact.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.03" data-order="|10|06|07|.03|" data-ref-path="10|06|07|.03" class="h__section">.03 Partners Eligible for EPT.</h3>
                <p>Partners eligible for EPT are:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.03#A">A.</span> Any partner within 60 calendar days of the patient’s diagnosis; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.03#B">B.</span> The most recent partner of a patient if the patient has not had sex in the 60 days before diagnosis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.04" data-order="|10|06|07|.04|" data-ref-path="10|06|07|.04" class="h__section">.04 Health Care Providers Authorized to Prescribe and Dispense EPT.</h3>
                <p>Notwithstanding any other provision of law, and only in accordance with their current scope of practice, EPT may be prescribed or dispensed by the following health care providers:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#A">A.</span> A physician licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 14, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#B">B.</span> An authorized physician assistant licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 15, Annotated Code of Maryland</a>, acting in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=15-302" title="">Health Occupations Article, §15-302</a>.2, Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#C">C.</span> An advanced practice registered nurse with prescriptive authority licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>, acting in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8" title="">Health Occupations Article, §8</a>–508, Annotated Code of Maryland; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#D">D.</span> A registered nurse employed by a local health department who complies with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#D(1)">(1)</span> The formulary developed and approved under Health-General Article, §3-403(b), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.04#D(2)">(2)</span> The requirements established under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-512" title="">Health Occupations Article, §8-512, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.04-1" data-order="|10|06|07|.04-1|" data-ref-path="10|06|07|.04-1" class="h__section">.04-1 Pharmacists Authorized to Dispense EPT.</h3>
                <p>Notwithstanding any other provision of law, a pharmacist licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, may dispense antibiotic therapy for EPT prescribed in accordance with <a class="internal-link " href="/us/md/exec/comar/10.06.07.04" title=".04 Health Care Providers Authorized to Prescribe and Dispense EPT.">Regulation .04 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.05" data-order="|10|06|07|.05|" data-ref-path="10|06|07|.05" class="h__section">.05 Prescribing and Dispensing EPT Medications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#A">A.</span> Antibiotic therapy prescribed or dispensed for EPT shall be in accordance with treatment recommendations from the Centers for Disease Control and Prevention.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B">B.</span> Prescribing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B(1)">(1)</span> A separate prescription shall be issued for each partner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B(2)">(2)</span> The designation “EPT” or “Expedited Partner Therapy” shall be included on the face of the prescription for each prescription issued.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B(3)">(3)</span> If the partner’s name is known, the prescription shall be issued in the partner’s name.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B(4)">(4)</span> If the partner’s name is unknown, the written designation “EPT” or “expedited partner therapy” shall be sufficient for the pharmacist to fill the prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#B(5)">(5)</span> An EPT prescription may not be refilled.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#C">C.</span> Dispensing. Each EPT medication label shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#C(1)">(1)</span> Include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#C(1)(a)">(a)</span> The designation “EPT” or “Expedited Partner Therapy”; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#C(1)(b)">(b)</span> The partner’s name, if known; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.05#C(2)">(2)</span> Comply with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">Health Occupations Article, §12-505, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.06" data-order="|10|06|07|.06|" data-ref-path="10|06|07|.06" class="h__section">.06 Counseling and Educational Information Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#A">A.</span> A health care provider prescribing or dispensing EPT to a patient shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#A(1)">(1)</span> Counsel the patient to encourage each partner to seek a personal physical assessment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#A(2)">(2)</span> Provide the patient with educational information for each partner, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.06.07.06#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#B">B.</span> A pharmacist dispensing EPT shall provide educational information for each partner, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.06.07.06#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C">C.</span> The educational information, that is available or comparable to that available on the Department’s website, shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C(1)">(1)</span> Advice for the partner to seek a medical evaluation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C(2)">(2)</span> Information about chlamydia, gonorrhea, and trichomoniasis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C(3)">(3)</span> Medication instructions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C(4)">(4)</span> Warnings about adverse drug or allergic reactions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.06#C(5)">(5)</span> Advice to abstain from sexual activity as required during treatment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.07" data-order="|10|06|07|.07|" data-ref-path="10|06|07|.07" class="h__section">.07 Documenting EPT in a Medical Chart.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.07#A">A.</span> A health care provider prescribing or dispensing EPT shall document the provision of EPT in the patient’s chart.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.07#B">B.</span> Documentation shall include the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.07#B(1)">(1)</span> Number of EPT prescriptions or medications provided to the patient for each partner; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.07#B(2)">(2)</span> Medication and dosage being provided to the patient for each partner.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.06.07.08" data-order="|10|06|07|.08|" data-ref-path="10|06|07|.08" class="h__section">.08 Reporting of Chlamydia and Gonorrhea by a Health Care Provider or Institution.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.08#A">A.</span> This chapter may not affect the obligation of a health care provider or institution to report to a health officer cases of chlamydia and gonorrhea and the treatment provided to those cases in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.04" title=".04 Reporting Procedures.">COMAR 10.06.01.04</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.06.07.08#B">B.</span> When reporting a case of chlamydia or gonorrhea for which EPT was prescribed or dispensed, a health care provider or institution shall report the number of partners for whom:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.08#B(1)">(1)</span> Prescriptions were provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.06.07.08#B(2)">(2)</span> Medications were dispensed.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.05" aria-label="Subtitle 05 FREESTANDING AMBULATORY CARE FACILITIES">
                <div class="h__ui">Previous</div>
                <span>Subtitle 05 FREESTANDING AMBULATORY CARE FACILITIES</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.07" aria-label="Subtitle 07 HOSPITALS">
                <div class="h__ui">Next</div>
                <span>Subtitle 07 HOSPITALS</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
